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1 Introduction
Overview
Definitions of pain have varied considerably over time and despite advances in
medical technology, notably the advent of sophisticated scanning techniques, general
agreement on what pain is and what it means continues to evade clinicians and
researchers (Merskey & Bogduk, 1994).
One of the central difficulties in defining pain is that the mechanisms are poorly
understood. Although popular and medical opinion attributes a direct lineage
between pain and tissue damage, the evidence supporting this association is
questionable (Sharp, 1997). A number of recent studies cast doubt on theories that
attempt to understand pain as a purely physical phenomenon. Jensen, Brant-
Zawadzki, Obuchowski, Modic, Malkasian & Ross (1994) reported that many people
with lumbar abnormalities (e.g. disk bulges) did not report back pain. By contrast,
Spitzer (1987) reports that many people complaining of back pain do not have any
identifiable pathology. Therefore, although no doubt related, the relationship
between physical impairment and reports of pain is only moderate (Waddell & Main,
1984).
Overall the evidence in the literature suggests that level of physical pathology is not
a clear predictor of the level of pain experience. The literature also describes a high
degree of variability in the way that individuals respond to chronic pain (Turk,
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1996a). Turner & Romano (1984) noted that not all pain patients suffering from
similar level of pain are depressed and disabled to the same degree. Several studies
have demonstrated that the association between pain, depression and disability
appears to be mediated by other variables; in particular psychosocial variables
(Fordyce, 1995; Lackner, Carosella & Feuerstein, 1996; Rudy, Kerns & Turk, 1988;
Waddell, Newton, Henderson, Somerville & Main, 1993)
These two strands of evidence taken together suggests that pathological changes
alone cannot explain reports of pain, pain-related disability or depression. As a
consequence, biomedical interventions targeting pathology alone may only be of
limited success in these selective areas and in the overall reduction of the pain
experience.
A number of multi-dimensional models have been advanced in an attempt to better
account for the perception of pain and its clinical phenomenology. In addition,
advances in the understanding of the mechanisms behind pain perception have aided
the development of effective treatment protocols, including those relating to
psychological treatment. The next section provides a general overview of three of the
more well established multi-dimensional models ofpain perception.
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1.1 Pain Perception
1.1.1 The Gate Control Theory (Melzack & Wall. 1968)
This theory attempts to integrate the role of both physiological and psychological
factors in chronic pain. Specifically, this theory advocates that incoming pain
messages encounter "nerve gates" in the spinal cord that when open allow the pain
messages to access cerebral structures and when closed prevent access.
Several factors may determine the response of the "nerve gates" to pain messages
and these include: the intensity of the pain message, competition from other
incoming nerve signals and signals from cortical and sub cortical structures which
increase or decrease the priority of the pain message. Further to these modulating
factors, recent research suggests that the message may be inhibited by endorphin
production from the hypothalamus at the sub cortical level. At the cortical level a
number of discrete anatomical structures are involved in attaching meaning to the
message based on the personal and social context in which the pain is experienced.
The model also advocates the role of descending messages from cortical and sub¬
cortical structures, which modulate the status of the "nerve gates". In times of
emotional dysregulation, descending messages from the brain may amplify the pain
signal at the "nerve gate" or alternatively descending messages may "close" the
nerve gate, preventing access.
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There has been significant debate over the actual physiological details of the model
(Nathan, 1976; Price, 1987). However, the Gate Control Theory has led to advances
in treatments, including neurophysiologically based treatments (North, 1989),
pharmacological advances (Fordyce, Roberts & Sternbach, 1985), and interventions
targeting modification of attentional and perceptual processing in the pain experience
( Turk, Meichenbaum & Genest, 1983).
1.1.2 Neuromatrix Theory (Melzack. 19991
Central to the neuromatrix theory is the assumption that the pain experience is
manufactured/derived by characteristic patterns of nerve activation across a
distributed neural network, termed the "body-self neuromatrix". This neuromatrix
has a genetic underpinning but is subject to modification by sensory experience and
learning. A further important feature of this model is that patterns of activation are
initially based on peripheral sensory input but once established can be activated
centrally to the exclusion of peripheral stimulation e.g. phantom limb.
According to Melzack (1999), a person's unique body-self neuromatrix is the
primary determinant of whether the organism experiences pain and is the basis for
individual differences observed. Building on the Gate Control Theory, pain
experience can be exacerbated/ suppressed by sensory and evaluative processes as
well as activation/deactivation of the endogenous opioid system (endorphins).
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The theory emphasises prior learning as an active agent in shaping the neuromatrix
by influencing interpretative processes and individual physiological and behavioural
response patterns. The neuromatrix theory also proposes that there is an interaction
between predisposing factors and acute stressors (Turk, 2002). This operates within a
diathesis-stress model framework and serves to explain the initial development of
pain. The pain then evolves into a stressor in and of itself and exacerbates the pain
experience. Evidence from animal research suggests that ongoing/ repetitive
experience of pain can lead to structural and functional changes that may cause
altered perceptual processing and contribute to pain chronicity (Woolf & Mannion,
1999). Once these changes have occurred they may contribute to the experience of
pain even after the initial cause has resolved. The permanence of these changes
explain the reports of pain in many chronic pain syndromes (FMS, whiplash
associated disorders and back pain) even when no physical pathology is identified.
This theory has provoked a degree of research interest but still requires systematic
investigation.
1.1.3 The Biopsvchosocial Model
The biopsychosocial model views pain as a complex interaction between biological,
psychological and social variables. It is assumed that these factors interact in a way
to shape a person's perception and response to illness. The biopsychosocial model is
based on an understanding of the dynamic interactions between these factors. The
relative influences of these biological, psychological and social factors may vary
during the evolution of a disease or impairment. During the acute phase for example
biological factors may prevail but over time psychological and social factors may
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assume a disproportionate role in accounting for symptoms. Crook, Weir & Tunks
(1989) suggest that there is considerable variability in behavioural and psychological
manifestations of dysfunction across individuals but also within the same individual
over time.













In the biopsychosocial model (Figure 1), biological factors may initiate, maintain and
modulate physical manifestations, whereas psychological variables influence
appraisals and perception of internal physiological signs and social factors shape
patients behavioural responses to the perception of their physical symptoms.
Operating in a dynamic and often reciprocal interplay, psychological factors may
influence biology by affecting hormone production (Bandura, O'Leary, Taylor,
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Gauthier & Gossard, 1987), brain structure and processes (Knost, Flor, Braun &
Birbaumer, 1997) and the autonomic nervous system (Flor, Turk & Birbaumer,
1985).
Additionally, behavioural responses may also affect biological status. A person may
avoid engaging in certain activities in order to reduce his or her experience of pain.
This avoidance has the effect of reducing the symptoms in the short term but
repeated avoidance leads to physical deconditioning which can exacerbate pain
experience longer term.
Summary
Chronic pain is a complex pathology for which explanations that emphasise a direct
lineage between tissue damage and the pain experience are now considered too
simplistic. Recent research has concentrated upon developing more complex
multidimensional models that may account better for the available data. The
biopsychosocial model emphasises the reciprocal interplay between specific domains
and permits a more dynamic understanding ofpain. The next sections consider the
psychological and social aspects of this model.
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1.2 Psychological Aspects of the Biopsychosocial Model of
Pain
1.2.1 Behavioural Components
Fordyce, Fowler, Lehmann & DeLateur (1968) and Fordyce (1976) identified a
distinction between the original cause of pain and displays of pain, known as pain
behaviours. Pain behaviours are subject to conditioning such that pain behaviours
may persist for longer than the expected healing time (Sanders, 1996, 2002). Pain
behaviours may be positively reinforced by attention from a spouse or a healthcare
provider. They may also be maintained by negative reinforcement by escape from
pain itself, by use of drugs, rest or avoidance ofundesirable activities such as work.
Fordyce, Shelton & Dundore (1982) suggested that anticipation of pain alone might
be sufficient to maintain avoidance behaviour through a process of respondent
learning. To clarify, once an acute pain problem becomes established fear of
activities associated with pain develop and avoidance ensues (Vlaeyen, Kole-
Snijders, Boeren & van Eek, 1995). Non-occurrence of pain following avoidance is a
powerful reinforcement for future reduction in activity. Following this, by a process
of operant learning, the conditioned response (avoidance of activity) now occurs in
the absence of an unconditioned stimulus (pain). Over time, avoidance leads to
anticipatory anxiety relating to activity. This anxiety is a conditioned stimulus for
sympathetic activation (the conditioned response). Sympathetic activation is
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maintained after the original unconditioned stimulus (injury) and unconditioned
response (pain) have subsided (Philips, 1987a).
Further to these processes, other studies have examined "stimulus generalisation"
where previously neutral activities elicit anxiety and anticipatory pain and are
avoided. Persistent avoidance prevents disconfirmation and no adjustment is made to
expectations of the outcome of engaging in these behaviours (Rachman & Arntz,
1991).
Behavioural learning theories usefully explain the development and maintenance of
pain behaviours but are limited in their applicability to treatment situations. Fordyce
(1976) noted that therapists needed to reach "a shared conceptualisation" with
patients. Even the founders of behavioural therapy had noted the need to "remove
patients mistaken beliefs" (Wolpe, 1958).
1.2.2 Cognitive Components
Individuals are not passive responders and actively seek to derive some meaning
from their experience. Experiences are appraised at cognitive and metacognitive
levels. Cognitions affect reports of pain, level of disability and response to treatment
(Flor & Turk, 1988; Jensen, Turner, Romano & Lawler, 1994; De- Good & Tait,
2001; Jensen, Turner, Romano & Karoly, 1991; Turk & Rudy, 1992). Cognitive
components that have received attention in the research literature relate to beliefs and
attributions in respect to the pain experience. Particular types of beliefs and
attribution are detailed in the section below.
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1.2.2.1 Beliefs and Attribution
Chronic pain patients differ greatly in their beliefs about pain. Beliefs that the pain is
an indication of continuing damage rather than a stable problem that may improve
are likely to increase suffering and behavioural dysfunction even though actual pain
experience is objectively the same (Flor & Turk, 1988).
Beliefs that pain is likely to persist can lead to a passive coping approach. Williams
& Keefe (1991), reported that beliefs that pain was an inexplicable mystery led to
minimal use of cognitive behavioural strategies to decrease pain.
Attributions regarding the significance of pain can effect perception of the
symptoms. Spiegel & Bloom (1983) reported, in cancer patients, that pain severity
could be predicted by interpretation of the pain. Specifically, patients who perceived
their pain as relating to a worsening of their underlying condition experienced more
pain that did those who held a more benign interpretation of their pain in spite of
comparable levels of disease progression.
1.2.2.2 Self-Efficacy
Self-efficacy is defined as a personal conviction that one can successfully execute a
course of action to produce a desired outcome in a given situation (Bandura, 1997).
This construct is considered to be a major mediator of therapeutic change.
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Efficacy judgements are based on prior performance, performance of others
considered to be similar to oneself on the task or similar tasks, verbal persuasion by
others that emphasise capabilities and perception of one's own state of arousal,
which is in part based on prior efficacy judgements. Converging evidence suggests
that perceived self-efficacy operates as a powerful cognitive factor in pain control
(Lorig, Chastain, Ung, Shoor & Holman, 1989), adaptive psychological functioning
(Lorig, Chastain, Ung, Shoor & Holman, 1989; Spinhoven, Ter Kuile, Linssen &
Gazendam, 1989), disability (Dolce, Crocker & Doleys, 1986), impairment (Lorig,
Chastain, Ung, Shoor & Holman, 1989) and treatment outcome (Philips, 1987b).
Cioffi (1991) has suggested four psychological mechanisms for the association
between self-efficacy and behavioural outcome. Firstly, high self-efficacy decreases
anxiety and as a consequence there is reduction in physiological activity, which may
mean that an individual approaches a task with less potentially distressing physical
information to begin with. Secondly, an efficacious individual will have the ability to
distract attention away from potentially distressing physiological sensations. Thirdly,
the efficacious individual may perceive distressing physical sensation but perseveres
in the face of them. Finally, physical sensations are neither ignored nor distressing
but are free to take on board a broad distribution ofmeanings.
1.2.2.3 Locus of Control
Research documents a positive relationship between a person's perceived sense of
control and that person's health (Tait De Good & Carron, 1982; Wells 1994). The
two main types of locus of control are internal, which reflects a belief in personal
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control over behaviour/health, and external, characterised as a belief that chance or
powerful others have control over behaviour/health. Patients with chronic pain who
have an internal locus of control are more likely to describe their pain as being less
frequent and severe (Lipchik, Milles & Covington, 1993). They also have more
effective pain control strategies than patients with an external locus of control
(Hadjistavropoulos & Craig, 1994). Similarly, Scharff, Turk & Marcus. (2000) have
suggested that patients' perceptions of the impact chronic headache has on their lives,
as well as perceived control of their headaches, may be associated with the intensity,
duration, and exacerbation of pain they experience.
Increased controllability of aversive stimuli reduces its impact (Jensen & Karoly
1991, Wells, 1994). while increased expectation ofuncontrollability of an aversive
stimuli leads to more intense reports ofpain perception upon stimulation (Leventhal
& Everhart, 1979).
Chronic pain sufferers typically perceive a lack of personal control and appear to
believe that they have limited ability to exert control over their pain (Turk & Rudy,
1988). The relationship between perceived controllability and pain has been
demonstrated in a variety of chronic pain syndromes. Increases in perceived
controllability over physiological activity have been associated with decreases in
migraine activity (Mizener, Thomas & Billings, 1988). Further, for patients with
either low back pain or rheumatoid arthritis, both general and situation specific
thoughts, relating to uncontrollability and helplessness, are stronger predictors of
pain and disability than are other disease variables (Flor & Turk, 1988). Perceptions
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of controllability have important implications for medication usage, activity levels
and psychological functioning (Jensen & Karoly, 1991).
Non-pharmacological therapy can have a beneficial impact upon perception of
control in patients with chronic pain. Coughlan, Ridout, Williams & Richardson
(1995) reported that patients increased their perception of personal control over their
pain following participation in a multi-disciplinary program. In addition, their
perception of the role of external influences affecting the experience of pain, such as
fate or powerful others, abated by the end of treatment. The authors of this study
concluded that a multidisciplinary approach to the management of chronic pain could
alter patients' beliefs about pain and change their locus of control. Helping patients
adopt an internal locus of control over pain is essential for successful treatment.
It is important to note that although the above study reported beneficial effects,
generally once cognitive belief structures are formed they can be resistant to change
and will remain stable over time. This is primarily due to the fact that individuals
with pain will actively avoid experiences that could potentially invalidate their
beliefs. In this way individuals do not receive corrective feedback and maladaptive
beliefs become strengthened under a mechanism of self reinforcement.
1.2.2.4 Cognitive Errors
A number of studies have explored the issue of somatic hypersensitivity in chronic
pain sufferers. Arntz & Schmidt (1989) report that pain sufferers experience
maladaptive changes in pain related information processing. Thus, there develops an
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internal focus of threat in which benign physical symptoms are interpreted as
painful/harmful sensations. These misinterpretations are also termed cognitive errors.
A cognitive error is a negatively distorted belief about oneself or one's situation.
Several studies have suggested a common set of cognitive errors that influence
perceptions of pain, affective distress and disability (Smith, Aberger, Follick &
Ahern, 1986; Smith, Follick, Ahern & Adams, 1986; Smith, Peck, Milan & Ward,
1990). Typical types of cognitive error include catastrophizing, overgeneralization,
personalisation and selective abstraction. Out of these, catastrophizing appears to be
a particularly potent cognitive error that influences pain and disability. A number of
studies have demonstrated that catastrophizing is important in determining the
reaction to pain. People who spontaneously used fewer catastrophizing self
statements rated experimentally induced pain as lower and tolerated painful stimuli
longer than those that reported using more catastrophizing self-statements
(Heyeneman, Fremouw, Gano, Kirkland & Fleiden, 1990; Spanos, Horton & Chaves,
1975). Other studies have shown that catastrophizing leads to greater dependence on
medication usage in post-surgical patients (Butler, Damarin, Beaulieu, Schwebel &
Thorn, 1989) and that reduction in catastrophic thinking are related to increases in
pain tolerance and reductions in physical and psychosocial impairment (Turner &
Clancy, 1986).
Summary
Psychological factors in chronic pain are best represented as an interplay between
behavioural and cognitive variables. Recent research has placed a greater emphasis
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on the role of cognitive variables in the experience of pain. In particular cognitive
variables such as locus of control, self-efficacy and catastrophic thinking have
received the most attention.
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1.3 Social Aspects of the Biopsychosociai Model
In addition to cognitive-behavioural factors, social resources are assumed to have an
impact on long-term chronic pain outcomes. Such resources include social networks
and perceived support from close others. The literature relating to social factors in
the experience of pain is divided between studies which assert that support from
significant others is detrimental to rehabilitation and those which emphasise the
beneficial effect of support on pain patients (Paulsen & Altmaier, 1995)
1,3.1 Detrimental Effects of Social Support
In terms of pain behaviours, Fordyce et al. (1973) proposed that patients displayed
such behaviour in an effort to communicate to others that they are in pain and
suffering. According to Fordyce (1976), pain behaviours are subject to operant
reinforcement and increase in frequency when the patient receives desirable
consequences or is able to avoid undesirable activities. The operant model suggests
that pain behaviours, while initially related to actual tissue damage, are later
maintained by the environmental contingencies through a process of operant
conditioning.
Block, Kremer & Gaylor (1980) suggested that the spouse is a particularly salient
discriminative cue for patients pain behaviours. They cite evidence that pain patients
reported different levels of pain in an experimental situation, depending on whether
they knew that they were being observed by their spouses or ward clerks. Block et al.
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(1990) stated that reports of pain severity were dependent on perceptions of spouse
support and whether the spouse was observing the interview. Patients who reported
that their spouses were inattentive in response to pain behaviours rated their pain as
lower when observed by their spouses and higher when observed by the ward clerk.
Conversely, pain patients who rated their spouses as attentive, in response to pain
behaviours, reported high levels of pain irrespective of who was observing. Other
studies have corroborated the importance of spouse reinforcement and social support
in-patient reported pain intensity (Flor, Turk & Scholz, 1987) and observed pain
behaviours (Gil, Keefe, Crisson & VanDalfsen, 1987; Romano, Turner, Friedman,
Bulcroft, Jensen & Hops, 1992).
1.3.2 Facilitative Effects of Social Support
In contrast, to the studies cited above a large body of literature exists suggesting that
social support is beneficial in the moderation of life stress, resulting in lower levels
of distress and less illness (Wallston et al. 1983; Cohen and Syme; 1985; Cohen and
Wills, 1985). In addition, social support may inhibit avoidance of physical and social
activities and have a beneficial impact on functional disability and pain (Cohen and
Wills, 1985; Keefe, Smith, Buffington, Gibson, Studts and Caldwell, 2002 and
Uchino, Cacioppo and Kiecolt-Glaser, 1996). Kerns and Turk (1984) demonstrated,
under experimental conditions, that patient perception of spouse support was
associated with lower levels of reported pain intensity and improved mood.
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Available evidence thus far suggests that, overall, social support affects rehabilitation
outcomes beneficially via a social support model and deleteriously through an
operant model. Competition between these models leads to the paradox that
supportive responses from spouses may have the potential to buffer against harmful
effects associated with pain (under the social support model) while the same
responses may reinforce maladaptive pain behaviours (under the operant model).
These discrepant findings may reflect the inconsistent definition and effects of
support on pain perception. Whereas some studies have considered the quantitative
or enacted aspects of support, other studies have considered the qualitative, or
perceived aspects of support.
Interestingly, while a number of studies have examined the impact of social support
on chronic pain very few studies have examined the impact of chronic pain on social
support and significant others. A study by Block & Boyer (1984) showed that
spouse's cognitive interpretation of the patient's chronic pain syndrome is closely
associated with the spouse's emotional adjustment and marital satisfaction. In
particular, perceptions that the patient has a positive attitude along with few
psychological problems all were associated with more positive emotional status in
spouses. Rowat & Knafl (1985) reported that the factors of uncertainty and
helplessness with regard to a partner with chronic pain were found to be central to
the distress experienced by the spouses. Flor, Turk & Sholtz (1987) reported that not
only is chronic pain associated with problems in the marital relationship but
heightened distress and physical symptoms in spouses as well. The existence of this
data suggests that in chronic pain detrimental effects on social support relationships
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is related less to the existence of a chronic pain condition per se but rather to patients'
and spouses' manner of coping with the situation.
Summary
The role of social support has been investigated in a number of chronic pain
populations including patients with cancer pain (Zaza & Baine, 2002), mixed
conditions (Gil, Keefe, Crisson &Van Dalfsen, 1986), rheumatoid arthritis (Evers et
al. 2003) and chronic lower back pain (Keefe & Block, 1982). Fewer studies have
examined the impact of chronic pain on spouses and relationships. Examination of
the literature reveals that no research, as yet, has been carried out looking at the
function of social support in headache or how therapy interacts with social support.
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1.4 Cognitive Behavioural Perspective on Pain
Considering intervention in chronic pain, the cognitive behavioural model has
become the most commonly accepted psychological conceptualisation of pain, as it
appears to have heuristic value in explaining the experience and response to chronic
pain. Early conceptualisation of a cognitive behavioural theory of pain by Turk,
Meichenbaum & Genest (1983) drew on the work of behavioural learning theorists
and ofBeck (1976),Beck, Rush, Shaw & Emery (1979) and Meichenbaum (1977).














The cognitive behavioural model draws heavily upon anxiety research. Salkovskis
(1991) describes the relationship between "threat cognitions" and "safety-seeking
behaviours", arguing that certain behaviours are understandable given a belief that
danger is imminent. In the model above (Fig 2) when pain is experienced there is an
immediate catastrophic interpretation regarding the significance of the pain. This
then incurs a fear ofmovement which may lead to further injury. Consequently, there
is an avoidance of the situation of action that resulted in the pain. While avoidance
reduces anxiety in the short term, the individual suffering from pain becomes
hypervigilant to somatic changes that might signify further suffering. Avoidance
leads to a decrease in self-efficacy beliefs regarding the pain and this can result in
feelings of learned helplessness, which may develop into depression. Reduction in
coping beliefs mean further pain is perceived as more threatening and interpreted
catastrophically as a vicious circle is created.
1.4.1 A Reformulation of the Cognitive Behavioural Model
In Fig 2, exposure to the pain is emphasised as a therapeutic technique with little
emphasis placed on the distorted cognitions that may have developed (see to the right
ofFig 2).
This omission led Sharp (2001) has to propose a reformulation of the cognitive
behavioural model (Fig 3). In this model, patients appraisals of the pain are given a
primary role in determining the level of disability encountered. Avoidance and/or
safety seeking behaviours prevent the disconfirmation of negative appraisals and
cognitions. At the same time anxiety and distress may maintain cognitive arousal and
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may reinforce beliefs that some underlying pathology exists. Anxiety and depression
enhance the probability that patients make cognitive errors and also maintains
avoidance which perpetuates the cycle.
The model also takes into account the likelihood that stress and iatrogenic factors
may exacerbate anxiety, arousal or maintain certain behaviours. Borrowing heavily
from the hypochondria literature (Salkovskis & Bass, 1997), Sharp (2001) draws
additional attention to the ways that doctors respond to a patient with chronic pain
which may inadvertently reinforce patient's anxieties and may reinforce excessive
disability and a passive approach (Kouyanou, Pither, Rabe-Hesketh & Wessley,
1998).
Sharp's (2001) model also implicates the role ofmeta-cognitions in the experience of
chronic pain. It is assumed that patients not only make negative appraisals about their
conditions but also interpret their pain-related thoughts as indicating something
negative about their condition. If these thoughts are anxiety provoking then the
patients may attempt to suppress them. This model predicts that attempts to suppress
or neutralise pain related thoughts might lead to an increase in their frequency and in
their perceived aversiveness (Salkovskis & Campbell, 1994; Salkovsiks, Westbrook,
Davis Jeavons & Gledhill, 1997).
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Fig 3: The reformulated cognitive-behavioural model of chronic pain.
(Sharp. 2000)
23
1.4.2 Evidence Supporting Reformulated Model
A range of recent research supports this reformulated model. Studies have shown that
if patients are worried about their pain (referred to as catastrophisers), they are more
likely to be hypervigilant (and be more somatically aware), which interferes with
attention but which also "amplifies somatosensory information and primes fear
mechanisms" (Crombez, Eccleston, Baeyens & Eelen, 1998). In addition, fear of
pain has been found to be a better predictor of avoidance than pain severity or
physical pathology (Crombez, Vervaet, Lysens, Baeyens & Eelen, 1998). Evidence
also exists that attempting to suppress pain related thoughts may be associated with
heightened pain experience (Sullivan, Rouse, Bishop & Johnston, 1997; Harvey &
Bryant, 1998).
The role of iatrogenic factors has been investigated by a number of studies.
Inappropriate and excessive use of medications and investigation may be associated
with patients' reports of symptomatology and with disability (Pither & Nicholas,
1991, Kouyanou, Pither, Rabe-Hesketh & Wessley, 1998).
Kouyanou et al. (1998) compared chronic pain patients whose symptoms were
medically explained with those whose symptoms could not be medically explained.
Findings suggested that patients whose symptoms could not be medically explained
showed a higher incidence of over-investigation and over prescribing. It was
hypothesised that the management of these patients was often unhelpful and, that by
frequently "disconfirming" patients pain and by suggesting that it was "all in their
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mind", they were maintaining the patient in the sick role. The authors suggested that
this maintenance could be attributed to the patients' determination to legitimise their
pain by seeking more investigations and more treatment. Thus the outcome
Kouyanou et al.'s(1998) study was to suggest that health care staff can be
instrumental in influencing patients beliefs about their pain and, as a consequence,
influence their pain related treatment-seeking behaviours.
Summary
Early conceptualisations of the cognitive behavioural model of pain placed a heavy
emphasis on the role of behavioural factors, such as avoidance, in the maintenance of
pain. Recent models acknowledge the role ofbehavioural factors, and have expanded
the range ofbehavioural factors involved, however, they place a greater emphasis on
the role of cognitive attributions and beliefs in the maintenance of chronic pain. In
so doing these models emphasise the utility of cognitive therapy in the treatment of
chronic pain.
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1.5 Chronic Pain and Psychopathology
1.5.1 Depression
Romano and Turner (1985) reported that 40-50 per cent of chronic pain patients
suffer from depression. In the majority of cases, depression occurs as a reaction to
the development of the chronic pain condition. Other studies have suggested that
chronic pain may be a masked form of depression and that emotional dysregulation is
expressed in somatic terms (Turk & Salovery, 1984). Several studies have reported
that depression is an important predictor of disability in chronic pain patients (Haley,
1985; Doan & Wadden, 1989) as well as a predictor of motivation for treatment
(Kerns & Haythornthwaite, 1988)
Depression does not appear to be automatically associated with the development of
chronic pain. It is not the case that all individuals with chronic pain are depressed. A
number of studies (Okifuji, Turk & Sherman, 2000, Rudy, Kerns & Turk, 1988)
suggest that pain alone is not a sufficient condition for the development of
depression. Such evidence has been used to support a cognitive behavioural
mediation model whereby perceptions and appraisals of the impact of the pain, the
degree to which the individual is able to exert control over their pain and the impact
it has upon their life, influence the development of depression. Rudy et al. (1988)
found that although depression and chronic pain were modestly correlated, this
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relationship was virtually zero when perceptions of impact and life control were
controlled for.
In longitudinal studies (Okifuji, et al. 2000), it has been reported that those
individuals who believed that they were able to continue to function, despite the pain
and that they could maintain some control over their pain and life, did not become
depressed.
1.5.2 Anxiety Disorders
Several studies have reported high rates of anxiety disorders among chronic pain
patients (Burton et al., 1997; Polatin et al, 1993). Asmudson, Jacobson, Allerdings &
Norton, (1996) have reported prevalence of anxiety disorders in chronic pain range
from 16.5 per cent to 28.8 per cent with panic disorder and generalised anxiety
disorder being the most commonly diagnosed. Burton et al. (1997) have reported that
current rates of anxiety disorder in chronic pain are higher than in the general
population.
Various studies view anxiety as a premorbid characteristic of some individuals with
chronic pain. Polatin et al. (1993) found that 95 per cent of those diagnosed with
anxiety disorders in their sample of patients with chronic lower back pain had
experienced anxiety disorders before the onset of pain. An emergent theory, based on
this evidence, is that pain is a somatic expression of anxiety.
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Other studies such as that ofGatchel, Garoalo Ellis & Holt (1996) suggest that
anxiety develops as a reaction to pain and increases in severity as the pain becomes
chronic. They found that although chronic pain patients had much higher rates of
overall psychopathology than did acute pain patients, anxiety disorders were
diagnosed frequently in both groups. These data support GatcheTs model of the
evolution from acute to chronic pain disability in which anxiety is considered to be a
common reaction to acute pain with more disabling and varied psychopathology
associated with chronic pain (Gatchel, 1991; Gatchel, 1996)
Once an anxiety response is in place, chronic pain may be maintained or exacerbated
through direct physiological mechanisms (Flor & Turk, 1989). Fear of pain and fear
ofmovement lead to further physical deconditioning through avoidance of physical
activities which contribute to the maintenance of the pain experience (Asmundson,
Norton & Norton, 1999). Anxiety is maintained through both avoidance and
continued operant learning mechanisms. Cognitive factors also become involved,
with avoidance leading to reduction in self efficacy beliefs and an increase in
expectancy that stimulation will increase pain (catastrophic thinking), which in turn
leads to further avoidance.
1.5.3 Somatoform Disorders
One ofthe most common diagnoses that a chronic patient pain will receive is that of
one of the somatoform disorders listed in the DSMIV (American Psychiatric
Association, 1994).
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"The common feature of the Somatoform Disorders is the presence of physical
symptoms that suggest a general medical condition and are not fully explained by a
general medical condition, by the direct effects of a substance or by another mental
disorder" (American Psychiatric Association, 1994).
Research that has attempted to identify a typical personality substrate to the
development of chronic pain, has consistently failed to demonstrate this to be the
case (Gatchel, 1996; Mayer & Gatchel, 1988). The literature shows that significant
pathology only develops after months following the onset of the pain condition.
However, there appears to be a subset of patients that demonstrate tendency to
express or communicate emotional distress as somatic symptoms (Fishbairn, 1999).
This syndrome has been labelled as somatisation. Main, Wood, Hollis, Spanswick &
Waddell (1992) use the term somatic distress to bring attention to the function of
somatisation as an alternate means of communicating emotional distress.
Although somatisation is a widespread phenomena in the chronic pain population,
there appears to be a subset of individuals for whom this has become amplified
(Fishbairn, 1999). For these patients, somatisation is conceptualized as a stable trait
(diathesis) that becomes activated in response to stressful situations and events that
the individual finds stressful, such as painful injury. Although this does not meet the
criteria for a somatoform pain disorder, somatisation has been found to be associated
with increased risk for developing chronic pain and greater health utilization in acute
pain patients (Dworkin, 1995) and poorer treatment outcomes in chronic pain
patients (Vassend, Krogstad & Dahl, 1995).
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A typical somatoform diagnosis is that of pain disorder. This is diagnosed when the
pain is the predominant focus of the clinical presentation, when the pain causes
significant distress or functional impairment and when psychological factors are
considered to have a large part to play in the onset, severity, exacerbation, or
maintenance of the pain (American Psychiatric Association, 1994).
Controversy over the current diagnostic definitions, the change in diagnostic criteria
and the subjectivity needed to make these diagnoses has made reliable and valid
prevalence estimates difficult to establish. Specific studies examining chronic lower
back pain have estimated prevalence to range from 73 per cent to 97 per cent (Polatin
et al. 1993; Fishbairn, 1986). These data were derived from diagnostic classification
prior to DSM IV. It is suggested that, given the inclusiveness of the current
diagnostic classification, the prevalence rates are likely to be very high, perhaps
above the estimates derived from the studies cited above.
1.5.4 Personality Disorders
A number of studies have reported high rates ofpersonality disorder among chronic
pain patients. Prevalence rates range from 31 per cent to 81 per cent which is well
above that exhibited in the general population (Burton et al. 1997; Gatchel et al.
1996; Weisberg, Gallagher, & Gorin, 1996). Little consistency has been found over
the relationship between chronic pain and specific types of personality disorder.
Several studies have reported that among the personality disorders, histrionic (Reich
et al. 1983), dependent, (Fishbain et al. 1986), paranoid (Polatin et al. 1993) and
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borderline (Weisberg et al. 1996) are most commonly diagnosed alongside chronic
pain. Inconsistency in the findings reflect discrepancies in patient samples,
diagnostic methods, and the overlap between the various DSM IV personality
disorder categories (Widiger, Trull, Hurt, Clarkin & Frances, 1987).
Again, as with other disorders associated with pain, there is a great deal of evidence
supporting the diathesis stress model between chronic pain and personality disorder.
According to Weisberg & Keefe (1997,1999), personality patterns that are associated
with marginally adaptive coping styles usually decompensate under the stress of
injury, disability and pain resulting in the expression of the personality disorder.
Summary
Chronic pain is co-morbid with a number ofpsychopathologies including depression,
anxiety, somatoform disorders and personality disorders. Given this co-morbidity,
questions arise as to what should be the primary focus of any therapy i.e. either
psychopathology or chronic pain or a combination of both. This decision rests on the
overall question ofwhether chronic pain is a somatic expression of emotional
dysfunction or whether emotional dysfunction is a reaction to the experience of pain.
No clear conclusion exists regarding this question.
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1.6 Mechanisms of Change in Pain
1.6.1 Transition from acute to chronic pain
Gatchel (1991) and Gatchel (1996) developed a broad conceptual model to explain
the transition from acute to chronic pain. This model defines three hypothesised
stages involved in this transition. Stage 1 is associated with fear, anxiety and worry
resulting from the perception of pain during the acute phase. This tends to be viewed
as a normal emotional reaction. If the pain persists for longer (e.g.2-4 months) then
there is a progression into stage 2. During stage 2, a wider array of behavioural-
psychological reactions and problems such as, learned helplessness, distress-anger
and somatisation develop. This theory is based on a diathesis stress model which
implies that problems in Stage 2 depend on the premorbid characteristics of the
individual. In those individuals with premorbid depression, stage 2 will lead to an
exacerbation of their problems.
Persistence of behavioural and psychological problems leads to stage 3, in which the
sick role is adopted. During this stage patients become excused from social
obligations and normal responsibilities. This can serve as a potent reinforcer for
maintaining the sick role. An additional maintaining process known as the physical
deconditioning syndrome (Mayer & Gatchel, 1988), which refers to a decrease in
physical capacity (strength, flexibility and endurance) can have a feedback effect on
levels of emotional well being and self-esteem. Such deleterious feedback increases
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this deconditioning as levels of motivation deteriorate (Gatchel, Baum & Krantz,
1989).
Gatchel & Epker (1999) delineated a number of risk factors or barriers that are
associated with the transition from acute to chronic pain (Table 1). These are
potential "flags" to clinicians in order to anticipate possible barriers to recovery.
Table 1 Summary of PsvchosocioeconomSc Risk Factors That May
Predict the Development of Chronic Pain Disability.
> High self reported pain and disability
> Elevation ofMMPI Scale 3 (Hysteria)
> Depression
> Somatisation
> Poor Coping Skills
> Poor quality of social support
> Unresolved workers' compensation/personal
injury cases
> Gender
> Reinforcement of pain behaviours
> Job dissatisfaction
> Maladaptive attitudes and beliefs about pain
> History of childhood sexual abuse
Note: From Gatchel and Epker (1999).
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1.6.2 Change In Treatment
The Transtheoretical Model (Prochaska & DiClemente, 1983; Prochaska,
DiClemente, & Norcross, 1992; Prochaska & Velicer, 1997) is an integrative model
and an attempt to define the underlying structure of change. The transtheoretical
approach uses the structure of intentional change as the foundation of its integrative
efforts (Prochaska, 1984). It is based on an analysis of the most popular theories of
psychotherapy, including affective, behavioural, cognitive, dynamic, experiential,
relationship, and systems approaches to therapy (Prochaska, 1984), and subsequent
integration of the key concepts from these theories. The model describes how people
modify problem behaviour or acquire a positive behaviour. The central organizing
construct of the model is the Stages of Change. The model also includes a series of
independent variables that facilitate change called the Processes of Change.
The Transtheoretical Model involves four primary constructs in explaining health
behaviour change: stages of change, processes of change, decisional balance (pros
and cons), and self-efficacy (temptations). The latter two are classed as intervening
variables.
1.6.2.1 Stages of Change
The Transtheoretical Model construes change as a process involving progress
through a series of five stages: Precontemplation, Contemplation, Preparation,
Action and Maintenance (see table 2)
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Individuals are entering a change situation, but they do not believe they
have a problem or know they do not want to change. Has no intention to
take action within the next 6 months
Individuals in this stage are beginning to be aware that the problem exists
or that they are bothered by something about themselves. They are
struggling to understand the problem (i.e., cause, solution) and are seeking
more information. They are considering change but have not made a
commitment to change. Intends to take action within the next 6 months
Individuals in this stage intend to take action. They have made some
reductions in their problem behaviours, but they have not yet reached a
criterion for effective action. Intends to take action within the next 30 days.
In the action stage, people have decided to change and have actively
started to work on changing, often seeking help to do so more effectively.
Has changed overt behaviour for less than 6 months
Individuals work to prevent relapse and consolidate gains accomplished
during the action stage. Has changed overt behaviour for more than 6
months.
Stages Of Change






Figure 4 Stages of Change: A Spiral Model
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The Stages of Change model implies that, for most persons, a change in behaviour
occurs gradually, with the patient moving from being uninterested, unaware or
unwilling to make a change (precontemplation), to considering a change
(contemplation), to deciding and preparing to make a change. Determined action is
then taken and, over time, attempts to maintain the new behaviour occur. Relapses
are almost inevitable and become part of the process of working toward life-long
change. Relapse is an opportunity to learn, gain missing information, redefine plans
and take action again. Prochaska (1994) found that people who take action and fail in
the next month, are twice as likely to succeed over the next six months as those who
don't take any action at all.
The Stages of Change model is useful for selecting appropriate interventions. By
identifying a patient's position in the change process, physicians can tailor the
intervention, usually with skills they already possess.
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Involves providing information regarding the
nature and risk of unsafe behaviours and the value
and drawbacks of the safer behavioural
alternatives.
Experiencing and expressing feelings about the
problem behavior and potential solutions/
psychodrama, grieving losses, role playing.
Allows the individual to reflect on the
consequences of his or her behaviour for other
people. It can include reconsideration of
perceptions of social norms and the opinions of
people important to him or her.
Entails the reappraisal of one's problem
Seeking to help others with similar situations.
Encourages the person to consider their
confidence in their ability to change and their
commitment to doing so.
Assists the person in a variety of ways, including
providing emotional support, modelling a set of
moral beliefs, and serving as a sounding board.
Developing internal and external rewards and
making them readily but contingently available to
improve the probability of the new behaviour
occurring or continuing.
Learning of healthier behaviours that can be
substituted for problem behaviours.
10. Stimulus Control Removal of cues for unhealthy behaviour.
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1.6.2.2 Processes Of Change
In explaining transition from stage to stage a set of cognitive and behavioural
processes are hypothesised that engender change. It is further hypothesised that
individuals in the earlier stages (e.g., precontemplation, contemplation, preparation)
are more likely to use cognitive-experiential processes (Table 3, Figure 5), such as
dramatic relief and self-re-evaluation. By contrast, individuals in the action and
maintenance stages are more likely to use behavioural processes, such as counter-
conditioning and stimulus control (Prochaska, 1984; Rossi and Wilcox).
Furthermore, individuals in the precontemplation stage use processes the least. Each
of the processes of change includes hundreds of techniques of change. For example,
an overeater may drink water when feeling tempted to snack, while someone in an
Alcoholics Anonymous program might pray when tempted to drink. Although using
different techniques, both are practising the process of counterconditioning:
substituting healthy responses for unhealthy ones. Successful changers use the
processes of change that are most appropriate to each stage of change.
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Figure 5: Illustration of the Processes Involved at Each Stage of Change
Stages of Change
Effective Introduction of Change Processes











In addition to the stages and processes of change, the model also includes two
intervening variables: decisional balance (the pros and cons ofbehaviour change)
and self-efficacy (situational confidence or temptations regarding the behaviour).
These intervening variables are strongly related to the individual's stage of change,
may be used to monitor intervention effectiveness, assist in assessing individual
progress toward behaviour change, and indicate potentially troublesome situations
that need to be targeted in order to make change and prevent relapse.
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1.6.3 Applicability of the Transtheoretical Model to Chronic Pain
The Transtheoretical model has previously been applied to a wide variety of problem
behaviours. These include smoking cessation, exercise, low fat diet, alcohol abuse,
weight control, condom use for HIV protection, organizational change, use of
sunscreens to prevent skin cancer, drug abuse, medical compliance, mammography
screening, and stress management.
The application of the transtheoretical model in chronic pain is a relatively new area
of research. It is increasingly apparent that a significant subset of individuals with
chronic pain are not successfully engaged in treatment for chronic pain (Turk &
Rudy, 1991). It has been suggested that patients may vary in the degree to which they
are ready to adopt a self management approach to pain and that this variable may
influence the engagement process as well as drop out and relapse rates (Kerns,
Rosenberg, Jamison, Caudill & Haythornwaite, 1997).
Unlike many traditional biomedical treatments, psychologically based pain
treatments require patients to make substantial changes in the way that they view and
cope with pain. It is hypothesised that only those individuals ready to consider
making these changes would be expected to benefit from psychological pain
treatments (Jensen, 1996).
The Transtheoretical model predicts that individuals at different stages of change
should evidence different treatment success rates. Individuals in the action stage
should show greater success than individuals in the contemplation and preparation
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stages. Treatment outcome research has supported this hypothesis for smoking
cessation (Ockene, Ockene, & Kristeller, 1988) and weight control (Prochaska,
DiClemente & Norcross, 1992). The model also predicts that a person's behaviour
should reflect their stage of change. Individuals in the precontemplative stage may be
expected to disagree with suggestions that a change in behaviour is needed and
would not be expected to exert effort towards making changes (Jensen, Neilson,
Romano, Hill & Turner 2000).
The stages of change model therefore has the potential to shed light on the reasons
for differences in patient outcome and help to identify those individuals who are
most likely to benefit from treatment. In addition, the theory has the potential to help
identify a persons particular stage of change and therein tailor intervention to
maximise therapeutic yield (Miller & Rollnick, 1991, Jensen, 1996, Kerns et al.
1997).
Summary
Studies are beginning to examine the applicability of the transtheoretical model, to
explain variable treatment outcomes. Studies have begun to examine the process of
health behaviour change in heterogeneous chronic pain samples (Kerns et al., 1997;
Kerns & Rosenberg, 2000; Jensen et al. 2000) including; fibromyalgic patients
(Jensen et al. 2000) and community based samples (Habib, Morrissey & Helmes,
2003). As yet no studies have looked at the transtheoretical model in relation to
health behaviour change in a chronic tension headache sample.
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1.7 Treatment in Chronic Pain
1.7.1 A Cognitive Behavioural Perspective
The chronic pain literature is replete with research relating to cognitive behavioural
intervention. Research relating to other psychotherapeutic intervention is noted only
by its general absence. Behavioural and cognitive treatments for chronic pain have
become established over the 30 years since their initial usage (Fordyce et al., 1968,
1973; Turk et al. 1983). While there are many published open trials of treatment, few
use control groups in which patients are randomised to treatments.
Reviews, however, conclude that there is strong, if not overwhelming evidence for
the efficacy of cognitive behavioural therapy (CBT) in restoring function and mood
and in reducing pain and disability-related behaviour (see e.g. McCracken, 1991;
Hawley, 1995; Morley, Eccleston & Williams, 1999; van Tulder et al., 2000).
Recently Morley, Eccleston & Williams (1999) conducted a systematic review and
meta-analysis of published Randomised Control Trials (RCTs) of CBT for chronic
pain, excluding headache. They concluded that cognitive-behavioural therapy
(including behaviour therapy and biofeedback) is effective relative to waiting list
control conditions. CBT produced significant changes in measures of pain
experience, mood/affect, cognitive coping and appraisal (reduction of negative
coping and increase in positive coping), pain behaviour and activity level, and social
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role function. When compared across the same range of outcomes with other
treatments or control conditions, the efficacy of CBT showed a smaller effect size
and was limited to the outcomes of pain experience, positive coping and social role
function. The overall effect sizes, in the order of 0.5, is less than those from larger
meta-analyses which consider psychological treatments for a variety of disorders
(Shadish et al., 1997).
Evidence in the literature point to four components of cognitive behavioural pain
interventions: education, skill acquisition, behavioural rehearsal and
generalisation/maintenance (Bradley, 1996). The skills acquisition phase for chronic
pain patients often includes graded activity scheduling, exercise, relaxation,
medication reduction and cognitive techniques (Linton, 1993; Philips & Rachman,
1996). Cognitive-behavioural models posit that improvement is due, in part, to
changes in patient coping strategies and beliefs (appraisal). The cognitive
behavioural method therefore attempts to change patterns of negative thoughts and
dysfunctional attitudes to foster more healthy and adaptive thoughts, emotions, and
actions in the patient.
Other methods of behavioural therapy are also integrated into the cognitive
behavioural approach. Relaxation techniques comprise a group of therapeutic
approaches that allow the patient to achieve non-directed relaxation, and are effective
in the treatment of chronic pain (Morley, Eccleston & Williams, 1999). Although
there are several ways to achieve relaxation, one method may be more effective than
another for an individual patient. Biofeedback techniques provide the patient with
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information on physiological functions to help in the relaxation process. Feedback
information that is provided to the patient can include electromyography, electro¬
encephalography, galvanometry, and temperature. Hypnotic techniques can help
induce states of directed relaxation.
Moore, Von Korff, Cherkin, Saunders & Lorig (2000) evaluated a brief cognitive
behavioural intervention for primary care back pain patients. Treatment effects were
not observed across all outcome domains. Participants assigned to the CBT
intervention showed significantly greater reductions in back-related worry and fear-
avoidance beliefs than the control group. Modest, but statistically significant, effects
on pain ratings and interference with activities were also observed.
Summary
In spite of the encouraging effects of psychosocial interventions in chronic pain
disorders, particularly CBT, the variability in outcomes between patients and the
magnitude and maintenance of effects in the long run is a point of continuing
discussion (e.g. Turk, 1990; McCracken, 1991; DeVellis and Blalock, 1993; Keefe
and van Horn, 1993; Hawley, 1995; Turk and Okifuji, 1998; Gatchel, 2001).
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1.8 Headache
1.8.1 Tension Type Headache
Definition
According to the Headache Classification Committee of the International Headache
Society (Headache Classification Committee of the International Headache Society
(EHS) (1988) headache disorders are classified into two categories: primary and
secondary. Primary headaches are defined as having no apparent underlying organic
disease process. Secondary headaches on the other hand are defined as symptomatic
of an underlying organic disease.
Tension-type headache is classified as a primary headache and is symptomatically
defined as pain that radiates in a band-like fashion bilaterally from the forehead to
the occiput. Pain often radiates to the neck muscles and is described as tightness,
pressure, or dull ache. Migraine-type features (unilateral, throbbing pain, nausea,
photophobia) are not present although migraine may be a co-morbid disorder
(Jensen, 1999). Tension-type headaches can last from 30 minutes to several days and
can be continuous in severe cases.
Tension-type headache is classified into two types: episodic and chronic. Generally,
episodic headaches occur randomly and are often the result of temporary stress,
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anxiety, fatigue or anger. A tension-type headache that occurs just about every day,
and may have been going on for months, is referred to as chronic.
1.8.1.1 Episodic tension-type headache
This is described as recurrent episodes of headache lasting minutes to days. The pain
is typically pressing or tightening in quality, ofmild to moderate intensity, bilateral
in location and does not worsen with routine physical activity. Nausea is absent, but
photophobia or phonophobia may occur.
Diagnostic criteria for Episodic Tension-Type Headache
A. At least 10 previous headache episodes fulfilling criteria B-D listed
below.
Number of days with such headache <180/year.
B. Headache lasting from 30 minutes to 7 days
C. At least two of the following pain characteristics:
1. Pressing/tightening (non-pulsating) quality
2. Mid or moderate intensity
3. Bilateral location
4. No aggravation by walking stairs or similar routine physical activity
D. Both of the following:
1. No nausea orvomiting (anorexia may occur)
2. Photophobia and phonophobia are absent, or one but not the other is
present
Source: Headache Classification Committee 1988.
Fiq 6: Definition of Episodic Tension Type Headache According to the
Headache Classification Committee. 1988
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1.8.1.2 Chronic tension-type headache
Headache is present for at least 15 ,days per month for at least 6 months. The pain is
typically pressing or tightening in quality, of mild to moderate intensity, bilateral in
location, and does not worsen with routine physical activity. Nausea, photophobia, or
phonophobia may occur.
Diagnostic criteria (IHS) Chronic Tension-Type Headache
A. Average headache frequency ofmore than 15 days permonth for over 6
months.
B. At least 2 of the following pain characteristics:
1. Pressing (non-pulsating) quality
2. Mild or moderate intensity (may inhibit, but not prohibit activities
3. Bilateral location
4. No aggravation by walking stairs or similar routine physical activity
C. Both of the following:
1. No vomiting
2. No more than one of the following: nausea, photophobia,
phonophobia
D. Secondary headache types not suggested or confirmed
Comment: Although this headache is generally continuous, it is seldom disabling. It
fluctuates in intensity. During moderate or severe exacerbations, it often has mild
migrainous features, such as throbbing, nausea, and mild hypersensitivity to light. Its
persistence makes it hard to endure. It commonly persists for many years, although
preventive medications often provide considerable relief
Fiq 7: Definition of Chronic Tension Type Headache According to
Headache Classification Committee. 1988.
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1.8.2 Epidemiology
In surveys of the general population in the industrialized part of the world, reported
prevalence of tension-type headache ranges from about 30 per cent to about 80 per
cent (Rasmussen, Jensen, Schroll, Olesen, 1991; Edmeads, Findlay, Tugwell, 1993:
Ramussen, 2001). Differences in definitions, methodology, and study population
may be largely responsible for this variation (Ramussen, 2001).
Tension-type headache varies widely in both frequency and severity, from rare short-
lasting episodes of discomfort (episodic type) to frequent, long-lasting, or even
disabling headaches (chronic type) (Jensen, 2001). A criticism of many
epidemiological studies is that pooling these extremes in an overall prevalence may
be misleading. Prevalence data should consider level of disability, severity, duration
and frequency of the disorder (Ramussen, 2001; Rasmussen, Jensen, Schroll, Olesen,
1991)
In a recent population-based study of a random general Danish population
(Rasmussen, Jensen, Schroll, Olesen, 1991), 41 per cent of subjects with tension-type
headaches did not have their daily activities inhibited because of the headache,
whereas 59 per cent had moderate or severe impairment of their daily activities. Of
subjects experiencing tension-type headache in the previous year, 59 per cent had it
one day a month or less, and 37 per cent several times a month. In the total
population, 3 per cent had chronic tension-type headache (i.e., headache 180 or more
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days a year; Rasmussen et al. 1991), which is in agreement with other reports which
examined epidemiology in the Canadian population (Pryse-Phillips, Findlay,
Tugwell, Edmeads, Murray & Nelson, 1992) and German population (Gobel,
Petersen-Braun, Soyka, 1994).
Population-based studies including data on the frequency of tension-type headache
have agreed with the Danish study (Rasmussen et al., 1991) in finding a rather large
proportion of subjects with mild and infrequent (once a month or less) tension-type
headache(Abramson, Elopp, Epstien, 1980; Hollnagel & Norrelund 1980; Nikiforow
1981; Rasmussen et al. 1991; Edmeads et al. 1993). In addition, these same studies
reach agreement on the one-year prevalence of frequent tension-type headache (more
that once a month) as being in the region of 20-30 per cent.
In terms of gender differences, tension-type headache is more prevalent in females
than in males (male/female ratio about 1:1.5) (Ramussen, 2001), and in both sexes
prevalence declines with age (Waters 1972, 1974, 1975; Philips 1977; Abramson et
al. 1980; Rasmussen et al. 1991; Pryse-Phillips et al. 1992). 1993; Rasmussen 1993).
The most common age at onset of tension-type headache is in the second decade,
somewhat younger than that ofmigraine (Rasmussen 1993).
1.8.3 Psvchophvsioloqy of Headache
For decades it has been a matter of debate whether the pain in tension-type headache
originates from myofascial tissues or from central mechanisms in the brain (Jensen,
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1999). Frequent tension-type headaches are now thought to be maintained primarily
by a central nervous system (CNS) dysfunction, not solely by input from peripheral
nerves in contracted facial, neck, and shoulder muscles (Olesen & Schoenen, 2000).
This CNS dysfunction may involve the sensitisation of pain transmission circuits in
the trigeminal nucleus, where input from nerves in the face and head is first
integrated and relayed toward the brain (Bendtsen & Ashina, 2000; Bendtsen,
Jensen, & Olesen, 1996; Olesen, 1991). Such sensitization would lower the threshold
of these circuits for the transmission of pain signals, so that little or no input from
peripheral nerves (noiciceptors) is required for the transmission of pain signals to the
brain. A dysfunction in supraspinal (limbic) pain modulation circuits may also
maintain pain by permitting, or even facilitating, the transmission of pain signals in
the brain (Schoenen, 1993; Schoenen, Jamart, Gerard, Lenar-duzzi, & Delwaide,
1987; Schoenen & Wang, 1997). This shift from peripheral to central mechanisms
has stimulated a resurgence of interest in the psychophysiology of tension-type
headache (Jensen, Ramussen, Pedersen, Olesen, 1993; Bendtsen, Jensen, Olesen,
1996; Langemark, Jensen, Jensen, Olesen, 1989).
The role of psychopathology as a mechanism in the maintenance of tension type
headache has received considerable attention. Headaches are generally reported to
occur in relation to emotional conflict and psychosocial stress, but the cause-effect
relationship is not clear. Stress and mental tension were the most frequently reported
precipitating factors but they occurred with similar frequency in tension-type
headache and migraine (Rasmussen 1993, Ulrich, Russel, Jensen, Olesen, 1996).
These results correspond with the findings of widely normal personality profiles in
50
individuals with episodic tension-type headache, whereas studies of subjects with the
chronic form often reveal a higher frequency of depression and anxiety (Holroyd,
France, Nash, Hursey, 1993; Rasmussen,1992; Mitsikostas &Thomas, 1999). As in
other chronic pain disorders, psychological abnormalities in tension-type headache
are viewed as secondary rather than primary, and anxiety and depression are
probably co-morbid with chronic tension-type headache (Jensen, 1999). However
this view is not consistent with a diathesis stress model in which a common
predisposing factor may account for both the presence of headache and
psychopathology. The attraction of the diathesis stress model necessitates further
work to be carried out in this area.
The progression of episodic tension-type headache into chronic tension-type
headache can occur spontaneously but often occurs in relation to frequent use of
analgesic medication. Repeated use of analgesics, especially ones containing caffeine
or butalbital, can lead to "rebound" headaches as each dose wears off and patients
then take another round of medication. Common features of chronic daily headache
associated with frequent analgesic use are early morning awakening with headache,
poor appetite, nausea, restlessness, irritability, memory or concentration problems,
and depression (Rapoport, Stang, Gutterman, Cady, Markley, Weeks et al. 1996).
Additionally, this view is to the neglect of important psychological processes, which
may also explain the transformation form acute pain to chronic pain. Again further
work needs to be conducted to understand these processes.
1.8.4 Headache Disorders and Co-morbid Psychopatholoqy
Epidemiological data suggest the prevalence of anxiety and mood disorders are not
elevated in Episodic Tension Type Headache "ETTH" (Merikangas, 1994;
Merikangas, Stevens, & Angst, 1993). However, it is doubtful this finding can be
generalised to Chronic Tension Type Headache "CTTH".
In clinical samples there is a high prevalence of both anxiety and mood disorders in
CTTH. Over 40 per cent ofCTTH sufferers in primary care settings receive either an
anxiety or mood disorder diagnosis by standardized diagnostic assessments
(Goncalves & Monteiro, 1993; Guidetti, Galli, Fabrizi, Giannantoni, Napoli, Bruni &
Trillo, 1998; Holroyd, Stensland, Lipchik, Hill, O' Donnell, Cordingley, 2000; Puca,
Genco, & Prudenzano, 1999). This figure is purportedly higher for CTTH sufferers
seen in speciality settings e.g. 45 per cent (Holroyd, Stensland, Lipchik, Hill, O'
Donnell, Cordingley, 2000). Moreover, this becomes an important therapeutic issue
as co-morbid anxiety or mood disorders appear to increase the disability associated
with CTTH's. Consequently, the identification and effective management of co-
morbid psychiatric disorders may play an important role in the management of
CTTH's (Holroyd et al., 2000).
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1.9 Psychological Management of Chronic Tension Type
Headache
1.9.1 Overview
Although medication is the most commonly used treatment for chronic tension-type
headache, a number of other methods have begun to amass evidence relating to
efficacy and effectiveness.
Holroyd (2002) reviewed three forms of psychological treatment which were judged
to have received empirical support for the management of tension-type headache: (a)
relaxation training (RLX), typically in the form of progressive muscle-relaxation
training; (b) electromyographic biofeedback training (EMG-BF), typically to reduce
muscle activity in forehead and often neck and shoulder muscles; and (c) specific
forms of cognitive-behavioral therapy (CBT) (i.e stress management, pain
management, minimal contact). Similar effect size and percentage improvement data
were found for the three behavioural treatments with a reported 40 per cent to 50 per
cent reduction in tension-type headache activity when results are averaged across
trials. This is consistent with results from earlier, more inclusive meta-analyses
(Blanchard, Andrasik, Ahles, Teders, & O'Keefe, 1980; Bogaards & ter Kuile, 1994;
Holroyd & Penzien, 1986) that used different statistical techniques. This evidence
has been cited by other authors who report "Behavioral treatments for tension-type
headache have a consistent body of research indicating efficacy" (McCrory, 2001).
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Blanchard, Appelbaum, Radnitz, Morrill, Michultka, Kirsch (1990) reported
reductions in headache frequency and medication usage with an overall effect size of
0.55 for the former and 0.42 for the latter using cognitive behavioural therapy.
Mosley, Grotheus, and Meeks (1995) extended this finding to an older (over 65 years
of age) patient population and found that CBT is more effective than RLX alone.
In a study examining the effectiveness of CBT on CTTH, Holroyd, O'Donnell,
Stensland, Lipchick, Cordingley & Carlson (2001) found that CBT was more
effective than pill placebo and comparable in effectiveness to tricyclic antidepressant
medication in reducing headache activity, analgesic medication use, and headache-
related disability.
1.9.2 Alternative Therapies
A recent systematic review of acupuncture treatment for headache (Melchart, Linde,
Fischer, White, Allais, Vickers et al. 1999) found 40 randomized controlled studies,
but only one study was categorized as "rigorous." In all of the trials of tension-type
headache that were examined, patients receiving acupuncture had superior outcomes,
compared with patients in the control groups. The authors of the review concluded
that, "overall, the existing evidence suggests that acupuncture has a role in the
treatment of recurrent headaches" (Melchart, Linde, Fischer, White, Allais, Vickers
et al. 1999).
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Studies have also been conducted investigating the role of spinal manipulation for
headache relief. (Boline, Kassak, Bronfort, Nelson & Anderson, 1995). In a trial
comparing manipulation with the use of amitriptyline, both modalities showed
improvement in headache intensity, frequency, and medication usage. However,
headache intensity was significantly less in the amitriptyline group. Four weeks after
cessation of therapy, patients in the spinal manipulation group continued to
experience benefits from the intervention.
1.9. 3 Therapeutic Mechanisms
The belief that EMG-BF training reduces tension headache activity by enabling
individuals to control sustained contractions in pericranial muscles is now being
challenged (Andrasik & Holroyd, 1980; Holroyd, Penzien, Holm, & Hursey, 1984).
A competing cognitive-attributional model that emphasises cognitive change as the
key therapeutic mechanism in EMG-BF and CBT has received initial support
(Holroyd & Penzien, 1983; Holroyd et al., 1984).
More recent studies provide additional support for this cognitive- attributional
model. In the first study, false feedback was used to manipulate patients' perceptions
of their performance during RLX (Blanchard, Kim, Hermann, & Steffek, 1993).
High-success feedback yielded larger improvements (54 per cent reduction) in
tension-type headache activity than moderate success feedback (21 per cent
reduction), even though behavioral ratings of actual relaxation behaviors during
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training did not differ in the high-success and moderate success feedback groups
(Poppen, 1988).
In a second study, combined EMG-BF and RLX produced larger reductions (51 per
cent of patients clinically improved) in tension-type headache activity than were
observed in untreated controls (15 per cent of patients clinically improved) (Rokicki,
Holroyd, France, Lipchik, France & Kvaal, 1997). A regression analysis revealed
that changes in self-efficacy scores over time explained more of the variance (43 per
cent) in improvement scores following treatment than changes in EMG activity
during biofeedback training. This suggested that changes in self-efficacy ratings were
a greater predictor of improvements following treatment.
1.9.4 Integrating Drug and Psychological Therapies
Reich & Gottesman (1993) examined the benefits of adding amitriptyline (up to 75
mg/day) to EMG-BF. The combination of amitriptyline HC1 and EMG-BF yielded
more rapid improvement in chronic tension-type headache activity than EMG-BF
alone; however, longitudinal data over a period of 14 months showed this combined
treatment showed no advantage over EMG-BF alone.
Holroyd et al. (2001) examined the separate and combined effects of CBT and
tricyclic antidepressant medication for CTTHs. Patients received one of four
treatments: tricyclic antidepressant medication (amitriptyline HC1 to 100 mg/day or
nortriptyline HC1 to 75 mg/day), medication placebo, limited-contact CBT (three
56
clinic sessions) plus antidepressant medication, or CBT plus placebo. Antidepressant
medication and CBT yielded similar reductions in CTTHs, analgesic medication use,
and headache-related disability at a 6-month evaluation, but again improvements
tended to be more rapid in the two antidepressant medication conditions than with
CBT. However, the combined treatment was more likely to produce clinically
significant reductions in CTTHs than either antidepressant medication alone or CBT
alone.
The combination of antidepressant medication and CBT appears to be a promising
treatment for chronic tension-type headache, particularly for patients who do not
respond to one of the individual treatments. Nonetheless, methods of enhancing the
effectiveness of this treatment are needed, because many patients continue to
experience frequent headaches even following the combined treatment. Information
about the long-term treatment outcomes with CTTH are also needed, because CTTH
may be more prone to relapse than ETTH, particularly following withdrawal of
antidepressant medication. The possibility that CBT or other psychological
interventions can help CTTH sufferers successfully withdraw from antidepressant
medication also deserves evaluation.
In spite of recent advances in medicine, it has been noted that most individuals with a
recurrent headache disorder do not have the means to effectively manage their
headaches (Adelman, 2000; Dowson & Jagger, 1999; Lipton, Stewart & Simon,
1998). In addition, a third of patients who receive medical treatment for headache
problems discontinue treatment because they are dissatisfied with the care they
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receive (Edmeads, Findlay, Tugwell, Pryse-Phillips, Nelson & Murray, 1993).
Advances in drug therapy alone are unlikely to remedy these difficulties. Rather,
effective headache management may require that individuals be empowered to
manage their own headache problems. Psychological treatment strategies can play a
central role in empowering patients, but to do this effectively psychological
treatment strategies must adapt to developments in the medical and public health
sciences and rigorously assess the benefits and limitations of psychological
interventions in the clinical settings where headache problems are treated.
Summary
Already, there is good empirical evidence supporting the use of cognitive
behavioural therapy alone or in conjunction with other theapies, in headache
(Holyroyd, 2002). However, Holyroyd, O'Donnell, Stensland, Lipchik, Cordingley
& Carlson (2001) have reported that while the effectiveness ofCBT is relatively well
established for chronic tension type headache, studies are needed to evaluate the
feasibility of integrating CBT into primary practice and speciality medical settings.
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1.10 Conclusion
Evidence from the literature reviewed thus far suggests that chronic pain can best be
understood as a multidimensional concept, which involves complex relationships
between biological, psychological and social factors. It follows that treatment of
chronic pain can only be partly successful if only one of these factors is addressed.
Treatment success requires a holistic approach that encompasses those factors
deemed to be important in the maintenance of chronic pain.
Recent research has focused heavily on the role of psychological factors in the
development and maintenance of chronic pain conditions. Psychological models of
pain have been developed which incorporate predisposing, precipitating and
maintaining factors in the development of chronic pain conditions. Further research
has been devoted to identifying specific common factors involved in the maintenance
of chronic pain. Identified factors include the presence of psychopathology,
catastrophic thinking, external locus of control/ poor self efficacy beliefs, current
stage in the stages of change model, level of social support, medication usage and
type of pain. Evidence suggests that each individual will vary in terms of the relative
contributions that each of these specific maintaining factors plays in the perpetuation
of their particular chronic pain condition.
In accepting the presence of differences in the relative contributions of each of these
factors, an obvious question arises about how effective generic treatment packages
are for individuals with chronic pain. A review of the literature indicates some
degree of variability in terms of the effectiveness of generic CBT packages in
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chronic pain. In studies specifically related to episodic and chronic forms of tension-
type headache, however, effectiveness of CBT is relatively well established. The
majority of studies which support CBT, have involved patients from primary care.
Studies are now needed to evaluate the effectiveness of on patients from speciality
medical settings.
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1.11 Aims of Study and Hypotheses
The aim of this research was to examine the effectiveness ofCognitive Behavioural
Therapy on patients with Chronic Tension Type Headache referred from an acute
medical setting. This study also aimed to the examine the impact of therapy on other
areas known to be implicated in the maintenance of chronic pain conditions. From
the review of the literature outlined above, it was hypothesised that:
1. Treatment as Usual plus Cognitive Behavioural Therapy participants will show a
significant reduction in Headache Frequency, Headache Duration, Headache Pain
Severity and Medication Usage compared to Treatment as Usual Participants
over time
2. Treatment as Usual plus Cognitive Behavioural Therapy participants will show a
significant shift towards the latter stages of the pain stages of change model (as
measured by the PSOCQ) compared to Treatment As Usual Participants over
time.
3. Treatment as Usual plus Cognitive Behavioural Therapy participants will show
significantly stronger beliefs concerning controllability of headaches (as
measured by the Multidimensional Health Locus ofControl Scale) compared to
Treatment As Usual Participants overtime.
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4. Treatment as Usual plus Cognitive Behavioural Therapy participants will show a
significant improvement in levels of emotional well being (as measured by Beck
Depression Inventory II and the Beck Anxiety Inventory) compared to Treatment
As Usual Participants over time.
5. Treatment as Usual plus Cognitive Behavioural Therapy participants will show a
significant improvement in levels of satisfaction with both emotional and
practical social support (as measured by the Significant Others Scale) compared




The study followed a 2 (Group)*2(Assessment) repeated measures design, which
assessed the effect of a cognitive behavioural intervention upon headache frequency,
severity and medication usage in chronic tension type headache sufferers. The design
also assessed what effect therapy had on other variables known to be involved in the
maintenance of chronic pain.
2.1 Participants
A total of24 participants were recruited from an outpatient Headache Clinic run at
the Western General Hospital. Participants were included in the current study if they
were diagnosed by the clinic specialist (R.C.) as having chronic tension type
headache according to criteria devised by the Headache Classification Committee of
the International Headache Society (1988).
Exclusion criteria included, experience ofmigraine, evidence of tumour, recent
substance abuse, systemic disease, a history of head trauma and involvement in other
forms of current psychotherapy.
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A total of 81 patients were randomly assigned to "treatment as usual" (TAU) or "a
treatment as usual plus cognitive behavioural therapy group" (TAU+CBT). Of these
patients 44 participants were allocated to the TAU+CBT group and 37 participants
were allocated to the TAU groups. Following dropouts a total of 12 participants
completed therapy in the TAU+CBT group and 23 participants remained in the TAU
group at week 10.
Informed consent to be involved in the research project was obtained from each
participant. The clinic specialist was responsible for approaching the patients
regarding the study and supplying both the patient information sheet and consent
form (appendix A) prior to contact by the principal researcher.
Following their agreement to take part an initial interview was arranged during
which all participants were asked to complete a series of questionnaires:
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2.2 Measures
2.2.1 Initial Assessment Data
Demographic information regarding age, gender, education and number ofmonths
since chronic headache onset were recorded. Using a diary format (appendix)
information was also collected over 10 weeks on number of headaches per day,
severity of the headaches rated on a likert scale of 0 (no pain) to 10 (maximum pain),




A number ofmeasures were used to assess psychological health.
• The Beck Anxiety Inventory (Beck, Epstein, Brown & Steer, 1988) is a 21 item
self report measure designed to assess the severity of anxiety symptoms. Each
BAI item is rated on a 4 point scale from 0 (not at all) to 3 (severely, I could
barely stand it). The summed score on all items of the BAI (range 0-63) taps the
severity of anxiety symptoms. Scores of <7 indicate minimal levels of anxiety,
scores of 8-15 indicate mild levels of anxiety, scores of 16-25 indicate moderate
levels of anxiety and scores of26-63 indicate severe levels of anxiety. The Beck
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Anxiety Inventory shows good internal consistency, convergent validity and
reliability (Beck, Epstein, Brown & Steer, 1988; Steer, Beck, Brown & Beck,
1993)
• The Beck Depression Inventory II (Beck & Steer, 1987) is a 21 item self report
measure designed to assess severity of depression in adults and adolescents aged
13 years and older. Each BDIII item comprises 4 representative statements that
are related to depressive symptoms and attitudes. These statements are arranged
based on the severity of their content and assigned an ascending score from 0-3.
The measure requires individuals to select the statement that is most relevant to
the way they have been feeling over the last week. A total score is derived by
summing up all item scores. This summed score (range 0-63) taps the severity of
depressive symptoms. Scores of<13 indicate minimal levels of depression,
scores of 14-19 indicate mild levels of depression, scores of20-28 indicate
moderate levels of depression and scores of 29-63 indicate severe levels of
Depression. The Beck Depression Inventory II shows good internal consistency,
convergent validity and test-retest reliability (Beck, Steer and Brown, 1996).
• The Pain Stages of Change Questionnaire (Kerns et al. 1997) is a thirty item self
report questionnaire designed to assess readiness to adopt a selfmanagement
approach in relation to pain. Individuals are asked to rate a series of statements
across four scales representing four stages of change, precontemplation,
contemplation, action and maintenance, on a scale of 1 (strongly disagree) to 5
(strongly agree). Scores are summed across each scale and the scale with the
highest score determines the stage of classification for that individual. The
66
individual scales show good internal consistency and test-re-test reliability
(Kerns et al. 1997).
• The Significant Others (Scale B) (Power, Champion & Aris, J988) is a self report
questionnaire designed to assess four different social support functions (2
emotional and 2 practical) in key individuals selected by the respondent. For each
of the four social support functions, each chosen individual is rated in terms of
the level of support received and the ideal level of support. Ratings are made
using seven point scales from 1 (never) and 7 (always). This instrument is
flexible and users decide how many individuals they wish to rate. Participants in
this study were asked to select three individuals. Raw scores are obtained for
each type of support for each individual on the questionnaire. Scores can be
summed across individuals to give separate measures of emotional support and
practical support. These scores are then divided by the number of individuals to
give a mean for each type of support. Three separate indices can be derived for
both emotional and practical support these are: actual level ofsupport, ideal level
ofsupport and the calculated discrepancy between actual and ideal. This
discrepancy provides an index of likely satisfaction with available support in
each area. This questionnaire has good test-re-test reliability and criterion
validity.
■ The Multidimensional Health Locus ofControl Scale (Wallston, Wallston &
DeVellis, 1978) is a multidimensional, 18-item three-factor scale derived from
Rotter's internal/external locus of control studies and is widely used in health
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behaviour research. Factor scores are generated for three subscales: (1) Internal;
(2) Powerful Others; and (3) Chance. Internal refers to the belief that the locus of
control for health is internal and that one stays or becomes healthy or sick as a
result of his or her behaviour. Powerful Others refers to the expectancy that
primarily doctors and other health professionals determine health. The Chance
subscale refers to generalised expectancies that factors, which determine health,
are such things as luck, fate, or chance. On each item individuals are asked to
rate their belief in a statement regarding responsibility for health. Individuals
answer on a six point scale from strongly disagree to strongly agree. Raw scores
for each scale are summed to give a total score for that scale. Scores range from
6-36 for each factor scale. Higher scores for each scale indicate greater adherence
to this particular belief. The test-retest reliability of the measure is established
(Wallston, & Wallston, 1981). The internal consistency of the individual scales
are all below a = .8 and this raises some question about the unity of each of the
scales.
On average these questionnaires took approximately 20-25 minutes to complete.
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2.3 Procedure
All participants were followed over a 10-week period. Over this 10-week period
participants were asked to record information relating to the headaches and
medication usage on a daily basis. At the end of the 10- week period all participants
were again asked to complete the same series of questionnaires as described above.
2.3.1 Protocol for Groups
• Treatment as usual group (TAU) (n=12)
Participants assigned to this group were followed up as usual by medical
practitioners at the Headache Clinic. They completed the questionnaires at week one
and again at week ten (see figure 2)
Week 1
Participants were given a set of questionnaires to complete and a headache diary.
Time was taken to explain how to fill in the diary over the next 10 weeks.
Week 10
Participant were re-contacted and given the second set of questionnaires. Participants
were asked to hand in their diaries. No further contact was made following this.
• Treatment as usual plus cognitive behavioural therapy group (TAU+
CBT) (n=12)
Participants assigned to this group were followed up as usual by medical
practitioners at the Headache Clinic. In addition, they underwent a 10-week course of
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cognitive behavioural therapy. Individuals completed the questionnaires at week one
and again at week ten.
Throughout the 10 weeks all participants were asked to fill in a daily headache diary
recording daily headache frequency (number of headaches per day), headache
duration (hours), pain severity (0-10) and over the counter medication usage (number
of tablets per day)
2.3.2 Therapy Protocol (See Fig 1)
Session One
This session was dedicated to performing an initial psychological assessment. This
involved noting the presenting problem, identifying the background history to this
problem along with current coping strategies. Details were taken on educational
history, family background and current circumstances. A formulation of the
presenting problem was developed based on this initial information. At this session
participants were asked to fill in the first series of questionnaires and time was taken
to explain the way in which the diaries should be completed for the following ten
weeks.
Session Two
This was a session used to give a comprehensive overview of the development of
chronic pain using a biopsychosocial diathesis-stress model. This allowed the
therapist to deliver information relating to the psychological factors involved in the
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development and maintenance of chronic pain without excluding the obvious
physical basis of the headaches. Information included, role of anxiety, fear and
avoidance behaviours (including reduction in physical activity), cognitive thinking
errors relating to pain and role of significant others. Also during this session issues
relating to over the counter medication usage in chronic pain were addressed. This
was an "add- on" and requested by the specialist at the headache clinic. On the
advice of the specialist emphasis was placed on stopping over the counter medication
usage due to its rebound effects. A motivational interviewing approach was taken to
explore reasons why individual participants found it difficult to stop over the counter
medication usage. Time was spent exploring ways in which to reduce medication
usage
Session Three (Relaxation)
Building on the information given in week two, relating to the impact that anxiety
and tension have on chronic pain, this session was dedicated to learning relaxation
techniques. This was done in session by use of a progressive muscular relaxation
audio tape which was copied for home use purposes. The use of diaphragmatic
breathing was also demonstrated during this session. Participants were instructed to
use these techniques through the following weeks on a daily basis.
Session Four (Pacing and Activity)
This session emphasised the danger of over-activity and how this may lead to
downward trend in overall activity levels. Time was taken to explain how the over¬
activity rest cycle develops and strategies were identified that could be used to
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overcome this. Advice was given on achieving a consistent baseline of activity and
the need to pace activity levels. Further information was given on goal setting and
ways to plan increases in overall activity levels. This session also incorporated
information relating to the importance ofmaintaining activity, particularly mild
exercise.
Session 5 (Thoughts and Pain)
A focus was placed on the relationship between stress and tension and how much
pain is experienced. Information was provided on the way that thoughts act as a
mediator between situations/events and feelings and behaviour. A distinction was
drawn between negative automatic thoughts and positive automatic thoughts in
particular relation to pain. Participants were instructed and given written information
on how to identify negative automatic thoughts and thinking errors along with
techniques to counter them. Homework was set during this session in which
participants had to keep a diary of thoughts relating to pain over the following week,
they were instructed in the use of countering techniques where negative automatic
thoughts were identified.
Session 6 (Review)
This early part of this session was used to evaluate the diaries from the week before.
The rest of this session was used to discuss any aspects of the previous sessions
participants had questions about and did not clearly understand. If problems were
identified during this session time was spent collaboratively seeking a solution.
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Session 7 (Review)
This session was used to review the participants progress. As in session 6 this session
was also used to discuss any aspects of the previous sessions that participants had
questions about or did not clearly understand. If problems were identified during this
session time was spent collaboratively seeking a solution.
Session 8 (Review)
This session was used to review progress to date. Participants were asked to fill out
another set of questionnaires and to hand in their diaries. This session marked the end
of contact.
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Figure 8: Graphic Representation of Procedure for Treatment As Usual
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2.4 Statistical Analysis & Result Reporting
2.4.1 Analyses
Statistical analyses were carried out using SPSS Version 10.1. Data were screened
for normal distribution. All variables were found to have a normal distribution with
the exception ofHeadache Frequency, Headache Duration and Medication Usage, all
of which were positively skewed. These were subjected to a log10 transform which
normalised the data.
Examination of differences between groups at week 1 on all measures was carried
out using independent T-tests. Repeated measures ANOVA were carried out on week
1 and week 10 data for the self report measures and independent T-tests were used to
examine differences in group means at week 10. Repeated measure ANOVA, with
group as the between factor, were carried out on week 1, week 5 and week 10 data
for Headache Frequency, Headache Duration, Pain Severity and Medication Usage
independent T-tests were used to examine differences in group means at week 5 and
10.
Regarding the use of parametric statistics for repeated measures, the sample size in
this study meant that the central limit theorem could not be utilised to specify the
normality of the distribution about the mean. A non-parametric analysis would have
employed the Friedman Test. However, this alternative will not accommodate a
between subjects factor. In summary, parametric statistics have been used where no
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non-parametric alternative could be discerned. Given the small sample size an appeal
is made citing the reported robustness of parametric tests when some of the
assumptions are violated (Clark-Carter, 1997)
2.4.2 Power Analysis
Effect size was based results on the study by Blanchard et al. (1990) which examined
the use of cognitive therapy for tension type headache. An effect size of 0.49 was
calculated for the treatment group using pre and post treatment means. Using
Cohen's Power Tables (1988) to achieve a .8 at .05 level number of subjects
required is reported as n=18.
2.4.3 Reporting of Results
In this study we started with a =.05 and power 1-P=.80. As the sample size was too
small, the level of power desired was not achieved and consequently the probability
ofmaking a Type II error became greater. In order to retain higher power, we have
insisted on reporting the results with a= . 10 (Cohen, 1992). Obviously, this increases
the probability of making a Type I error, and to this end we have erred on the side of
caution and referred to them as trends only. Reporting these trends seems justified
under the rubric that if the a priori probability of the null hypothesis being false is
high, then the probability ofmaking a Type I error is correspondingly decreased, and
a lower alpha level is reasonable. In this study we have assumed that the a priori
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probability is high, based on similar studies, involving larger sample sizes, finding




Table 4 summarises overall demographic information and demographic information
relating to treatment and control participants.





Male (n) 5 (41.7%) 4 (33.3%) 9 (37.5%)
Female (n) 7 (58.3%) 8 (66.7%) 15 (62.5%)
Age (yr.)
Mean 38.17 42.5 40.33
SD 13.31 12.72 12.92
Education (yr.)
Mean 15.17 14.58 14.88
SD 2.92 2.64 2.74
Onset (mths)
Mean 20.08 19.08 19.58
SD 7.14 3.92 5.66
Between and within groups there were more females than males. Independent
samples t-tests showed no significant difference between groups in terms of age (t=
.815, df=22, p= n.s, 2-tailed), or educational attainment (t= .513, df=22, p= n.s., 2-
tailed).
A measure was taken of the length of time individuals had been suffering from
chronic pain prior to attending the headache clinic. This measure related to the time
the individual had been suffering more than 15 headaches a month. An independent
samples t-test revealed no significant difference between length of time since onset
of pain between groups (t= .425, df=22, p= n.s., 2-tailed).
3.1.1 Attrition Rate for Therapy
Attrition rate was based on the number of treatment participants recruited into the
study who either did not turn up for the initial assessment or attended and did not
complete therapy. A total of44 participants were assigned to the treatment group. Of
these 32 (72 per cent) did not complete therapy, this further broke down into 13 (41
per cent) who did not attend the initial assessment and 19 who attended but did not
complete therapy (59 per cent). Of these 19 the frequency distribution (graph 1)
graphically illustrates the various points in time individuals left treatment.
Graph 1: Frequency Distribution of Patient Attrition (for those who













Retrospective analyses of the explanations for non-completion of therapy is broadly
summarised in table 5 below.
Table 5: Explanations for Non Completion of Therapy
Explanation for Non Completion Number ofPatients
(n—19)
No Explanation 14
Felt Therapy Was Not Helping 2
Difficulty Attending 3
Due to Pain 2
Due to Work Commitments 1
Data on patients who did not complete therapy were not included in subsequent
analysis. This was due to the fact that patients left at a very early stage of the
treatment program and data was therefore incomplete.
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3.2 Self Report Measures
3.2.1 Pain Stages of Change Questionnaire
Following the protocol established by Jensen, Nielson, Romano, Hill & Turner
(2000) each participant was classified into one of the four stages of change based on
his or her highest PSOCQ scale score. In those cases where an individual exhibited
two or more scale scores that were equal, the individual was placed into the "higher"
of the two stages this again followed the precedent set by (Jensen et al. 2000). This
only occurred two times (out of the 24 participant) at week 1 and four times at week
10. Distribution of participants at week 1 and week 10 is summarised in Table (6).
Table 6: Distribution of Participants in Each Stage of Change atWeek 1
and Week 10
Pain Stages ofChange Questionnaire
Precontemplation Contemplation Action Maintenance
Pre Post Pre Post Pre Post Pre Post
Treatment 0 0 6 1 3 0 3 11
(0%) (0%) (50%) (8.3 %) (25%) (0%) (25%) (91.6%)
Control 0 0 8 10 0 1 4 1
(0%) (0%) (66.6%) (83.3 %) (0%) (8.3 %) (33.3 %) (8.3 %)
Overall 0 0 14 11 3 1 7 12
(0%) (0%) (58.3 %) (45.8%) (12.5 %) (4.16 %) (29.2 %) (50%)
An analysis of the distribution of ranks between groups was conducted using a
Mann-Whitney U Test which revealed no significant difference (U=66.0, p= n.s.) at
week 1. A Ilirther analysis of the distribution of ranks was conducted at week 10 this
revealed a significant difference (U=12.5, p=.001). This suggests that
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some participants had shifted classification over the 10 week period. Further
examination of Table 6 suggests that the treatment group shows reduction in the
distribution of participants in the contemplation and action stage and an increase in
numbers in the maintenance stage at week 10. The control group shows a surprising
opposite trend with a reduction in the distribution of participants in the maintenance
stage and an increase in the contemplation stage at week 10.
3.2.2 Repeated Measures on Pain Stages of Change Questionnaire
Analyses revealed no significant differences between the treatment and control group
at baseline (week one)
Separate repeated measure ANOVA's were carried out on each of the sub scales of
the Pain Stages of Change Questionnaire comparing data at week one and week ten,
to assess the main effect of time on measures. Interaction effect between treatment
and control subjects were also assessed using repeated measures ANOVAs. Results
of the repeated measure ANOVA's can be viewed in Table 7 and are described in
text.
3.2.2.1 Precontemplation Scale
A significant main effect was observed with a significant decrease in scores found
over time. A significant between group interaction was characterised by a reduction
in means for scores for the treatment group and no change in means for the control
group (see Table 7).
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3.2.2.2 Contemplation Scale
There was no effect of time on this variable. However, a significant interaction was
characterised by a small increase in means for the control group and a decrease in
means for the treatment group (see Table 7). An independent t-test revealed a
significant difference in means (t=3.47, df=22, p=.002, 2-tailed) at week 10 with a
higher mean for control.
3.2.2.3 Action Scale
A significant main effect was observed with a decrease from baseline to post-
treatment. A significant interaction was characterised by a greater decrement in
means for the treatment group compared to the control group (see Table 7). An
independent t-test revealed a significant difference in means (t=5.31, df=22, p=.000,
2-tailed) at week 10 with a higher mean for control.
3.2.2.4 Maintenance Scale
A significant main effect was observed along with a significant interaction. The
interaction was characterised by an increase in means for the treatment group and an
overall decrease in means in the control group (see Table 7) An independent t-test
revealed a significant difference in means (t=4.89, df=22, p=.000, 2-tailed) at week
10 with a lower mean for control
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3.2.2 Multidimensional Health Locus of Control
Table 7 shows overall means and standard deviations on the Internal, Chance and
Powerful Others sub-scales as well as means and standard deviations for the control
and treatment groups on these sub-scales at week 1 and week 10.
3.2.2.1 Internal Sub Scale
A significant main effect was found with an increase in this scale from week 1 to
week 10 (see Table 7). There was no significant interaction between groups. An
independent t-test revealed a significant difference in means (t=4.582, df=22, p=.000,
2-tailed) at week 10 with a higher mean for treatment group.
3.2.2.2 Chance Sub Scale
No significant main effect or interaction was found (see Table 7). An independent t-
test revealed no significant difference in means (t=1.86, df=22, p= n.s., 2-tailed) at
week 10.
3.2.2.3 Powerful Others Scale
No significant main effect was observed for this subscale although a significant
interaction was revealed which was characterised by an increase in means for the
control group and a decrease in means for the treatment group (see Table 7). An
independent t-test revealed no significant difference in means (t=.240, df=22, p=
n.s., 2-tailed) at week 10.
3.2.3 Beck Depression inventory
Means and standard deviation for the Beck Depression Inventory at week 1 and week
10 can be seen in Table 7. No main effect or interaction effect were observed for this
scale (see Table 7). An independent t-test revealed no significant difference in means
(t=1.22, df=22, p= n.s., 2-tailed) at week 10.
Using available cut-off scores participants were classified into one of four groups
based on their overall score: minimal (0-13), mild (14-19), moderate (20-28) and
severe (29-63). Table 8 shows the distribution of participants in each of the groups
at week 1 and week 10.
Table 8: Distribution of Participants Across Categories of Severity at
Week 1 and Week 10 on the Beck Depression Inventory
Beck Depression Inventory

















Treatment 4 6 3 4 4 1 1 1
(n=12) (33.3 %) (50 %) (25 %) (33.3 %) (33.3 %) (8.3 %) (8.3 %) (8.3 %)
Control 2 2 4 4 4 3 2 3
(n=12) (16.7%) (16.7%) (33.3 %) (33.3 %) (33.3 %) (25 %) (16.7%) (25 %)
Overall 6 8 7 8 8 4 3 4
(n=24) (25 %) (33.3 %) (29.2 %) (33.3 %) (33.3 %) (16.7 %) (12.5 %) (16.7 %)
An analysis of the distribution of ranks between groups was conducted using a
Mann-Whitney U Test which revealed no significant difference (U=59.0, p= n.s.) at
week 1. A further analysis of the distribution of ranks was conducted at week 10 this
also revealed a significant difference (U=40, p=.05). This suggests that some
participants had shifted classification over the 10 week period. Examination of the
87
distributions in Table 8 suggests that the distribution of participants in the control
groups remains relatively stable between week 1 and week 10. By contrast, the
treatment group shows reduction in numbers in the moderate category and an
increase in the minimal and mild categories between week 1 and week 10.
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3.2.4 Beck Anxiety Inventory
Means and standard deviation for the Beck Anxiety Inventory can be seen in Table 9.
There were no significant main effects and no significant interactions between
groups over time. An independent t-test revealed no significant difference in means
(t=l.32, df=22, p= n.s., 2-tailed) at week 10.
Using available cut-off scores participants were classified into one of four groups
based on their overall score: minimal (0-7), mild (8-15), moderate (16-25) and severe
(26-63). Table 9 summarises distribution of classification of participants at week 1
and week 10.
Table 9: Distribution of Participants Across Categories of Severity at
Week 1 and Week 10 on the Beck Anxiety Inventory
Beck Anxiety Inventoiy
Minimal Mild Moderate Severe
Week Week Week Week Week Week Week Week
1 10 1 10 1 10 1 10
Treatment 4 6 3 4 3 1 2 1
(n=12) (33.3 %) (50 %) (25 %) (33.3 %) (25 %) (8.3 %) (16.7%) (8.3 %)
Control 3 2 3 4 4 4 2 2
(n=12) (25 %) (16.7%) (25 %) (33.3 %) (33.3 %) (33.3 %) (16.7%) (16.7%)
Overall 7 8 6 8 7 5 4 3
(n=24) (29.2 %) (33.3 %) (25 %) (33.3 %) (29.2 %) (20.8 %) (16.7 %) (12.5 %)
An analysis of the distribution of ranks between groups was conducted using a
Mann-Whitney U Test which revealed no significant difference (U=65.5, p= n.s.). A
further analysis of the distribution of ranks was conducted at week 10 this also
revealed no significant difference (U=41, p=.078) although there may be a trend
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toward significance suggesting some participants had shifted classification during the
10 week period. Looking at Table 9 it appears that the control group appears stable in
terms of its distribution of participants between week 1 and week 10. By contrast, the
treatment group shows reductions in numbers in the moderate and severe categories
and increases in numbers in the minimal and mild categories.
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3.2.5 Significant Others Scale
Means and standard deviations for the actual level of support, ideal level of support
and discrepancy sub-scales, that comprise the practical and emotional levels of
support scales, for week 1 and week 10 can be seen in Table 7.
Repeated Measures
No main effects were found for any of the sub-scales (see Table 7). A significant
interaction was found for the Practical Support Discrepancy score, which was
characterised by an increase in mean for the control group and a decrease in mean for
the treatment group. In addition independent t-tests revealed no significant
differences in means at week 10 on any of the sub scales.
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3.3 Treatment Measures
3.3.1 Treatment Measures (Week 1)
Table 10 displays the means and standard deviations at week 1 (in bold) and week 10
for Headache Frequency, Headache Duration, Headache Pain Severity and
Medication Usage. Distribution of data was positively skewed for headache
frequency, headache duration and medication usage. Data was subjected to log 10
transform for those data sets that were skewed. These transformations resulted in
normal distributions for each of the data sets (see table 10)
Independent t-tests revealed no significant differences on Headache Frequency
(t=1.77, dfr=22, p= n.s., 2-tailed), Headache Duration (t=.483, df=22, p= n.s., 2-
tailed), Pain Severity (t=. 189, df=22, p= n.s., 2-tailed) and Medication Usage
(t=.371, df=22, p= n.s., 2-tailed) at week one.
Table 10: Raw (Skewed) and Transformed Data for Headache
Frequency, Headache Duration & Medication Usage
Raw Data Transformed Data









Headache 2.59 .472 7.0 .918 .572 .472 1.49 .918
Duration 1.43 .472 1.33 .918 -.065 .472 .064 .918
Medication 1.13 .472 1.51 .918 -.217 .472 .080 .918
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3.3.2 Treatment Repeated Measures
Preliminary analyses of distribution revealed that all week 5 and week 10 measures
were normally distributed. Table 12 displays the means and standard deviations at
week 1, week 5 and week 10 for Headache Frequency, Headache Duration,
Headache Pain Severity and Medication Usage.
For the purposes of repeated measures data that was transformed at week 1 also had
to be transformed at week 5 and week 10. Following this transform data maintained
its normal distribution. Repeated Measures ANOVA's were conducted on the week
1, week 5 and week 10 data, with group (treatment vs. control) as a between factor.
Results of the repeated measures ANOVA's can be seen in Tablel2.
Table 12: Summary of Main Effects and Interactions
d.f. F Sig.
Main Effects
Headache Frequency 1,22 3.77 ..04*
Headache Duration 1,22 3.74 .04*
Pain Severity 1,22 2.85 ..08
Medication Usage 1,22 4.31 .03*
Interactions
Headache Frequency* Group 1,22 4.00 .034*
Headache Duration* Group 1,22 3.13 .06
Pain Severity* Group 1,22 7.69 .003*
Medication Usage* Group 1,22 2.65 .09
* Significant at .05
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Independent t-tests were performed on week 5 and week 10 data to examine the
presence of group differences. Results of these analyses can be viewed in Table 13.




Headache Frequency 1.34 n.s. 22
HeadacheDuration .605 n.s. 22
Pain Severity .197 n.s. 22
Medication Usage .90 n.s. 22
Week 10 Comparison
Headache Frequency .452 n.s. 22
Headache Duration 1.813 .083 22
Pain Severity 1.878 .074 22
Medication Usage 2.105 .047* 22
* Significant a. 05, 2 tailed.
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3.3.2.1 Headache Frequency
Repeated measures analysis of variance revealed a significant main effect for
headache frequency between pre-treatment and post-treatment. Inspection of the
means showed that there was an overall reduction in headache frequency for both
treatment and control participants. A significant interaction was also observed for
Group * Headache Frequency with greater reduction of headache frequency over
time for the treatment participants. Inspection of the means showed that treatment
participants began with a higher headache frequency at week one compared with
control participants; this discrepancy was analysed and found to be not significant
(see Table 13). The means also demonstrate that treatment participants never achieve
the absolute level of reduction found in the control participants but again this
discrepancy is not significant
Graph 2: Plot of Average Daily Headache Frequency for TAU and
CBT+TAU Groups atWeek 1. Week 5 & Week 10
-Treatment
-Control





Repeated measures analysis of variance revealed a significant main effect for
headache duration. Inspection of the means showed that there was an overall
reduction in headache duration for both treatment and control participants. There was
a trend towards significance for the interaction Group* Duration implying both
groups do not show similar reduction in headache duration over time. Independent t-
tests revealed no significant difference between means at week 5 although there was
a possible tend towards significance at week 10 (see table 13).
Graph 3: Plot of Average Daily Headache Duration for TAU and






























Repeated measures analysis of variance revealed a main effect for headache pain.
Inspection of the means showed that there was an overall reduction in headache pain
severity for the treatment group but a small increase for the control group. A
significant interaction was found for Group * Headache Pain Severity. Independent t-
tests revealed no significant difference between group means at week 5 although
there was a trend towards significance at week 10 (see Table 13).
Graph 4: Plot of Average Daily Pain Severity for TAU and CBT+TAU at














Analyses revealed a main effect for medication usage and a trend towards
significance for an interaction for Group * Medication Usage (see Table 11).
Independent t-tests revealed no significant difference in means between groups at
week 5 but a significant difference between groups at week 10 with controls
exhibiting a higher mean than the treatment group (see table 13)
Graph 5: Plot of Average Daily Medication Usage for TAU and CBT+TAU


























Graphs 6, 7, 8 and 9 have been included to encapsulate all data points collected. The
graphs demonstrate that although there is some variation trends over time support
results of the statistical analysis using the three data points ofweek 1, week 5 and
week 10.
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Graph6:PlotofHeadacheFrequencyover10weeksf rTreatm ntAnCo tr lG oups Weeks
Graph7:PlotofHe dacheDur tionver10we ksf rTreatmentAndCont olGr ups Wopke










3.4.1 Success of Treatment
Treatment success was measured across four dependent variables: headache
frequency, headache duration, pain severity and medication usage. An index of
percentage change between week one and week ten for these variables was
calculated within subjects by using the following formula:
Week 1 Score- Week 2 Score x 100
Week 1 Score
3.4.1.1 Headache Frequency Index
Overall 16.7 per cent of individuals showed no change over time, 20.83 per cent
showed an increase in daily headache frequency (mean change =26.5 per cent) and
62.5 per cent showed a reduction in daily headache frequency (mean change =40.1
percent) overtime. In the treatment group 100 per cent (mean change=3 8.24 per
cent) of individuals showed a reduction in daily headache frequency over time. In the
control group 33.3 per cent of individuals showed no change over time, 41.7 per
cent (mean change =26.5 per cent) showed an increase in daily headache frequency
and 25 per cent (mean change =47.62 per cent) showed a reduction in daily
headache frequency over time.
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3.4.1.2 Duration of Headache Index
Overall 70.83% (mean change=47.84%) of individuals showed a reduction in
headache duration while 29.17% (mean change =43.9%) demonstrated an increase in
headache duration. In the treatment group 83.3% (mean change =55.09%) showed a
reduction in headache duration while 16.7% (mean change =64.8%) demonstrated an
increase in headache duration. In the control group 58.3% (mean change =37.5%)
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showed a reduction in headache duration while 41.7% (mean change =35.67%)
demonstrated an increase in headache duration.





Across groups 58.33% (mean change =41.1%) of individuals showed a reduction in
pain severity over time, 8.3% showed no improvement and 33.3% (mean change
=99%) demonstrated an increase in pain severity over time. In the treatment group
83.3% (mean change =42.7%) showed a reduction in pain severity while 16.7%
(mean change =6.43%) demonstrated an increase in pain severity. In the control
group 33.3% (mean change =37.08%) showed a reduction in pain severity, 16.7%
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showed no change in pain severity and 50% (mean change =130.61%) demonstrated
an increase in headache duration








Across groups 58.33% (mean change =57.5%) of individuals showed a reduction in
medication usage over time, 20.83% showed no improvement and 20.83% (mean
change =55.5%) demonstrated an increase in medication usage over time. In the
treatment group 75% (mean change =69.4%) showed a reduction in medication
usage, 16.7% showed no change medication usage severity and 8.3% (mean change
=60%) demonstrated an increase in medication usage. In the control group 41.7%
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(mean change =36.11%) showed a reduction in medication usage, 25% showed no
change in medication usage and 33.3% (mean change =54.2%) demonstrated an
increase in medication usage.






Effect sizes for the treatment group were calculated on all of the treatment measures
using week 1 and week 10 data the equation for two dependent samples below
(Rosnow & Rosenthal, 1996, Cohen 1988)
d — Mi - M2 / Cpooled
where
Spooled = V[(a!2+ CT22) / 2]
Calculated effect sizes were d=55 for headache frequency, d= .82 for headache
duration, d=.81 for pain severity, d=88 for medication usage.
A correction statistic was used due to the small sample size to give an unbiased
estimate of d (Hedges & Olkin, 1985)
Calculated value of d x ^ 1 - + n ) - 9} ^
The correction statistic was calculated as being 0.95. All effect sizes were then
adjusted using this statistic
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Adjusted effect sizes were d=.52 (medium) for headache frequency, d= .78




The aim of this research project was to examine the effectiveness of Cognitive
Behavioural Therapy in chronic tension type headache. Findings are discussed in
relation to previous literature, with methodological flaws evaluated. The relevance of
these findings in terms of future research is discussed.
4.1 Discussion of main findings in relation to headache
measures
4.1.1 Effectiveness of Cognitive Behavioural Therapy
We hypothesised that Cognitive Behavioural Therapy plus TAU would lead to a
greater reduction in headache frequency, headache duration, headache pain severity
and medication usage over time than compared to TAU alone.
Results of this study provide additional support for Cognitive Behavioural Therapy
being an effective approach in chronic pain. This study also provides preliminary
support for the inclusion of cognitive behavioural therapy in treating patients seen at
a speciality medical setting.
In terms of findings on the headache specific measures there appears to be a general
decrease in headache frequency, duration and medication usage over time. Measure
of pain severity did not reach formal significance for a main effect but was
considered to be approaching significance. These main effects arise due to the
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decrements in the treatment group. Scrutiny of the interactions from the repeated
measures analyses demonstrate that for headache frequency and pain severity the
treatment group show greater improvements, in terms of symptom reduction over
time, than the control group. Other interactions were approaching significance and
given a larger sample size may well have reached significance. In these interactions
the trend is for the treatment group to show greater improvement over time compared
to controls.
Considering the effect size for each of these measures it is clear that they are in
general above the mean effect size of .5 seen in other studies looking at CBT and
chronic pain (Holyroyd, 2002, Blanchard et al. 1990; Holyroyd et al. 1977). In
addition, the amount of improvement in percentage terms is comparable with
estimates derived from a meta-analysis by Goslin, Gray & Mc Rory (1999).
The presence ofmain effects, interactions and generally large effect sizes are unusual
compared to other studies in the general chronic pain literature but not unexpected
findings in this study. There are a number of factors, which might have led to these
findings.
4.1.1.1 Patient Characteristics
Primarily, patient characteristics appear to play a large role in the variability of
findings between studies in the general chronic pain literature. Evidence suggests
that patients with rheumatoid arthritis (RA) engaged in CBT and behavioural
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treatments have non-significant to small effects on indicators of physical and
psychological functioning at post-treatment, and non-significant effects at follow-up
assessments (Hawley, 1995; Riemsma et al., 2002; see also, McCracken, 1991;
Riemsma et ah, 1999). By contrast, meta-analyses of CBT for various chronic pain
disorders, such as chronic low back pain or osteoarthritis, have revealed more
promising effects (Hawley, 1995; Morley et ah, 1999; van Tulder et ah, 2000). The
limited effects ofCBT for RA have frequently been ascribed to the heterogeneity of
patients. On this basis, it has been argued that not all patients may receive benefits
from generic treatments. Indeed it follows that the more heterogeneous the patient
sample, the less likely that a generic treatment could encapsulate the varying needs
of each individual. In view of the individual variability between patients with chronic
pain, various attempts have been made to classify patients into more homogeneous
subgroups and identify patients that may benefit from psychosocial interventions. For
example, it has been repeatedly shown in various chronic pain disorders that
subgroups of patients who are relatively well-adjusted might only receive limited
benefits from CBT. Groups of patients with heightened distress levels and
dysfunctional cognitive-behavioural factors benefit most from CBT (e.g. Turk and
Rudy, 1988, 1990a; Turk, 1990; Main et al., 1992; Klapow et al., 1993, 1995; Strong
et al., 1994; Turk and Okifuji, 1998; Gatchel, 2001). Retrospective analyses of CBT
effects in fibromyalgia patients provided preliminary support for this view, indicating
that patients characterized by high distress levels and dysfunctional cognitive-
behavioural factors benefited more from CBT than those relatively well-adjusted or
whose impairment was mainly related to social functioning (Turk et al., 1998).
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In this study participants were relatively homogenous in that all suffered from a
particular type of chronic pain and initial data suggest that the majority of the
participants were in the clinical range for anxiety and depression. In addition, it is
important to note that there may be something additional about the individuals in this
study that we were unable to measure. A 72 per cent drop out rate was noted for the
treatment group suggesting that the group completing treatment represented a
minority of the patients referred in total. One suggestion is that these patients are
qualitatively different from those individuals that dropped out that made them more
receptive to cognitive behavioural therapy. This is not a question that can be
answered here as the data for the participants who dropped out is limited. However
this is a possible avenue of future research.
4.1.1.2 Treatment Specificity
A second factor involves the treatment specificity. Effect studies of CBT usually
consist of generic treatments with multiple cognitive and behavioural modules,
assuming that the different components are relevant and effective for patients.
However, in view of the various problems from which patients with chronic pain
suffer, treatment programs tailored to patients' clinical needs may increase the
effectiveness of CBT in chronic pain patients (e.g. Turk, 1990; Fry and Wong, 1991;
Turk and Okifuji, 1998; Gatchel, 2001). In addition, applying treatment modules
matched to individual patient profiles and directed to the outcome from which
patients suffer most, is likely to increase patient satisfaction with treatment and
decrease attrition rates (see e.g. Turk and Rudy, 1990b). In this study the treatment
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programme was specific in terms of psychoeducation, which focused on a
psychological theory of chronic headache and contained cognitive and behavioural
components which made specific to headache. It is interesting to note that the
numbers of studies which outline their protocol for therapy are few in number. This
raises the issue of how well one CBT study can be compared with another. In
addition, it raises a more fundamental issue about what is meant by CBT in various
studies.
4.1.1.3 Timing of Treatment
It has been assumed that treatment effectiveness depends on the timing of treatment.
For example, it has been suggested that patients develop a relatively stable way of
coping with chronic pain over time (Sinclair and Wallston, 2001). It is hypothesised
that dysfunctional cognitive-behavioral patterns may be less established and easier to
modify at an earlier stage of the disease than later on. This would imply increased
CBT effectiveness for patients suffering for a shorter time from their complaints (e.g.
Philips and Jahan-shahi, 1985; DeVellis and Blalock, 1993; Peters et al., 2000;
Sinclair and Wallston, 2001). In addition, interventions at an earlier stage of the
disease have, by definition, a greater chance of having more long-term benefits and
possibly preventing a worse long-term disease (Parker & Wright, 1995).
Dysfunctional cognitive-behavioural factors, that predict a worse long-term disease
outcome in chronic pain patients, have been shown to be already established in the
initial years of the disease (Evers et al., 1997, 1998a, 2002; Smith et al., 1997;
Kraaimaat et al., 1995; Sinclair and Wallston, 2001).
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The patients in this study had a mean onset of chronic pain approximately a year and
a half before being seen for cognitive behavioural therapy. Other studies report
mean onset duration of headache as being 11.17 years (Johnson & Thorn, 1989), 10.7
years (Holroyd, Nash & Pingel, 1991), 15.6 years (Richardson & Mc Grath, 1989).
Clearly patients in the present study are receiving cognitive behaviour therapy at an
unprecedented early stage compared to reports in the literature and this may account
for observed effect sizes.
4.1.1.4 Combining Treatments
Combing single treatment modalities can increase the effectiveness of intervention
(Holroyd, 2002). The most common non-medication treatments for headache are
biofeedback, relaxation training, and cognitive therapy. While evidence exists for
their effectiveness as single treatment modalities, other studies have examined the
effects of combining treatment modalities. One study (Blanchard et al. 1985) showed
improvement in 39 per cent of 94 patients with headache using relaxation training
alone. Adding biofeedback increased the portion of patients experiencing
improvement to 56 per cent. In another study, Blanchard, Appelbaum, Guarnieri,
Morrill & Dentinger (1987) reported that combining relaxation with EMG
biofeedback led to improvement that was maintained at five years' follow-up.
Other studies have investigated cognitive psychotherapy alone and also in
combination with other behavioural treatments for chronic tension-type headache.
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Among these trials, at least 50 percent of patients had reduced symptoms when
treated with progressive relaxation, cognitive therapy, or a combination of the two
(Attanasio, Andraisk & Blanchard, 1987). This study used a combination of
cognitive therapy and relaxation, which may have also contributed to the observed
effect sizes.
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4.2 Discussion of findings in relation to General Measures
4.2.1 Pain Stages of Change Questionnaire
Ajnother question to be considered is in what way treatment achieves effectiveness,
or more precisely, how treatment incurs change in individuals. The aim of cognitive
therapy in chronic pain is to emphasise the adoption of a self- management approach
(Gatchel &Turk, 1996). If treatment is successful, it is assumed that individuals are
adopting a transfer of responsibility in the management of their own health.
However, this requires a shift in competencies but also a shift in the way they view
pain. Clearly, adopting a self-management programme necessitates a readiness to
change. The transtheoretical model describes how people modify problem behaviour
or acquire a positive behaviour. In chronic pain readiness to change is measured
using the Pain Stages of Change Questionnaire. Studies that utilise the
transtheoretical model generally aim to predict treatment success based on the
particular stage a given individual occupies at a given point in time. No studies in the
pain literature have examined the reverse and considered the effects of therapy on
this model and how success in treatment may be reflected as progression through the
stages of change during therapy.
We hypothesised that successful therapy should incur a shift towards the latter stages
of the pain stages of change model for treatment participants. By contrast, control
participants should show no such shift. This study found that over the course of
therapy the treatment groups showed a shift towards the maintenance stages of the
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model. It may be hypothesised that the shift in the treatment group reflects an
increased commitment to self management and this leads to greater adherence to
recommendations of skill acquisition and practice, which may in turn lead to
improved pain management. If therapy mediated this change then it was expected
that controls would show no such shift in their stage of change. Indeed the control
group who showed no such shift in fact some individuals in the control group
showed a relapse in terms of the stage they occupied at week 1 and then at week 10.
In this study, individuals in both groups were generally classified in the
contemplation, action or maintenance stages at week 1. This is perhaps not surprising
as they are already attempting to seek out help in a specialist setting. Indeed,
although speculative, many of these individuals may have had numerous
investigations to identify the physical cause of the pain suggesting that they are
already at least in a contemplation stage if not in an action stage of change.
4.2.2 Multidimensional Heath Locus of Control Questionnaire
We hypothesised that treatment success would reflect an increase in beliefs
concerning the controllability of pain. This was partially supported by trends
observed in the data. We employed the Multidimensional Health Locus of Control
Questionnaire to examine changes over time in internal beliefs, chance beliefs and
powerful other beliefs. TAU+CBT participants showed a similar pattern to controls
on the internal scale with increased scores over time suggesting that both groups
view health as more in their control. By week 10 the scores on the internal scale were
120
significantly higher for the CBT+TAU group than the TAU group. An interaction on
the powerful other scale was characterised by a reduction in means over time for the
CBT+TAU group while the TAU group showed an increase over time.
Extending these findings, it may be further hypothesised that treatment serves to
increase levels of self-efficacy in dealing with pain by changing locus of control
beliefs towards internality and away from powerful others. In addition, it might be
speculated that in a reciprocal relationship treatment success is dependent upon this
change occurring.
4.2.3 Emotional Wellbeing
We hypothesised that treatment success should be reflected in greater emotional well
being in TAU+CBT participants in contrast to theTAU participants who should show
no such change in wellbeing. We employed two measures to assess wellbeing; the
Beck Depression Inventory and the Beck Anxiety Inventory.
4.2.3.1 Beck Depression Inventory
Interestingly, results showed no effect of treatment on depression scores. There was
no overall change in these scores over time and no interaction between the groups
and scores over time. As previously noted, Romano and Turner (1985) reported that
40-50 per cent of chronic pain patients suffer from depression. In the majority of
cases, the depression occurs as a reaction to the development of the chronic pain
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condition. Other studies have suggested that chronic pain may be a masked form of
depression and that emotional dysregulation is expressed in somatic terms (Turk &
Salovery, 1984). This latter issue leads to an interesting prediction. If chronic pain is
a somatic externalisation of an underlying clinical depression then those therapies
that a specifically tailored towards increasing self management of the pain condition
only would be expected to have little impact upon the underlying depression.
Conversely, if depression is simply a reaction to the onset of chronic pain, then these
same therapies should have some degree of impact on overall depression as pain
symptoms become more manageable. Results from this study suggest that
improvements in the ability to manage pain, as demonstrated by reduction in the
various headache measures, do not impact upon depression scores. Taken in isolation
this would appear to lend support to the theory that chronic pain is a somatic
externalisation ofunderlying depression.
4.2.3.2 Beck Anxiety Inventory
Results demonstrated an interaction between group and scores on the Beck Anxiety
Inventory that was approaching significance. This might be expected to reach
significance with a larger sample size. This trend suggests that therapy may have the
effect of reducing anxiety scores to an extent not observed in the control group.
As with depression, studies exist that view anxiety as a premorbid characteristic of
some individuals with chronic pain. Polatin et al. (1993) found that 95 per cent of
those diagnosed with anxiety disorders in their sample of patients with chronic lower
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back pain had experienced anxiety disorders before the onset of pain. Based on this
evidence, it is hypothesised that pain is a somatic expression of anxiety. Other
studies such as that of Gatchel, Garoalo Ellis & Holt (1996) suggest that anxiety
develops as a reaction to pain and increases in severity as the pain becomes chronic.
They found that although chronic pain patients had much higher rates of overall
psychopathology than did acute pain patients, anxiety disorders were diagnosed
frequently in both groups.
Unlike results from the Beck Depression Inventory, these results suggest that
anxiety, certainly for participants in this study, may be a reaction to the development
of chronic pain rather than being a premorbid characteristic. Importantly though,
while the therapy contained no specific elements relating to coping with depression
there was a session devoted to relaxation. Relaxation is a specific skill in learning to
deal with anxiety and this may explain the difference in effect of therapy over these
two measures ofwellbeing.
A final note may be that changes in depression scores occur after a latency in which
patients consolidate their skills and continue to self-manage their pain consistently.
Data from this study, which analysed shifts in classification (minimal, mild,
moderate, severe) on the Beck Depression Inventory, suggest that a number of
treatment participants descend through the classification stages following treatment,
to lesser classification categories. On a critical note, this analysis removes much of
the fine grained detail necessary for firm conclusions. However, it may indicate the
beginnings of change not seen in more detailed analysis. Follow up data would
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clarify this issue of whether change in depression scores occurs following a latency
period.
4.2.4 Significant Others Scale
We hypothesised that treatment success would be reflected by increases in social
support satisfaction. This literature relating to social support in chronic pain is replete
with studies that implicate social supports as discriminative cues for illness
behaviour (Block et al.,1990, Fordyce, 1973, 1976). Literature also exists, albeit to a
lesser extent, on the facilitative effects of social support in chronic pain (Wallston et
al. 1983; Cohen and Syme; 1985; Cohen and Wills, 1985). Our study was interested
in how a therapy, which emphasises the adoption of a self-management approach,
affects levels of satisfaction of social support. We employed the Significant Others
Scale that allowed an analysis of changes in satisfaction of emotional and practical
support from significant other.
Analyses supported the hypothesis only for the measure of practical support.
Participants in the treatment group reported less discrepancy between actual and
ideal levels of practical support. This was characterised by an increase in the actual
support available and a reduction in the ideal support required. Although the changes
in means are small it might be hypothesised that a therapy which endorses a self-
management approach reduces levels of actual support needed by the patient in the
first instance. This has the paradoxical effect of increasing the amount of available
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support as the significant other as problems in the relationship are reduced. No
studies have examined this complex relationship.
Given that the majority of measures associated with the Significant Others Scale did
not show any significant differences at post treatment between groups this issue
becomes an important point for speculative discussion.
A simple explanation may relate to the salience of the particular aspect of social
support under scrutiny. Intuitively, it could be advocated that practical levels of
social support are far more salient than changes in emotional levels of support (Flor,
Turk & Scholz, 1987). Thus, the greater salience of changes in practical support
increases the likelihood of their detection at an early stage. On the other hand,
changes in emotional levels of support, being less salient, will tend to be less
detectable at an early stage and may evolve more slowly over time. This leads to the
argument that if emotional levels of support are tested over a long enough period of
time group differences may become apparent. In essence, the lack of significant
differences may be the result of the short interim period between testing at pre and
post treatment.
Measurement issues may also account for lack of differences between groups. Social
support is not a unitary concept and at present no measure exists which encompasses
all aspects of the term. The Significant Others Scale measures the functionality of
relationships in practical and emotional terms. It is also possible to examine social
support from a structural perspective (Cohen & Ashby Wills, 1985). Structural
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measures seek to describe the existence of relationships. The lack of group
differences may be attributable to the measure that we employed. Further, the
greatest changes may not exist at a functional level but at the structural level at least
in the early stages. The functional nature of the assessment tool used in this study
means that such changes could not be detected.
Another important issue regarding measurement relates to the specificity or globality
of the measure employed (Cohen & Ashby Wills, 1985). Specific measures assess a
specific aspect of social support while global measures take a number of different
aspects of social support and combine them. The Significant Others Scale is a
moderately specific functional questionnaire. Again the lack of group differences
may be attributable to the measure that we employed. We assessed specific aspects
of social support where in fact gross changes may have occurred on a global level.
The specific nature of the assessment tool used in this study once again meant that
such changes could not be detected.
Finally, as with all self-report measures there are a number of problems with
responder bias due to social desirability or inaccurate recall over time (Jensen &
Karoly, 1991). It is therefore possible that while differences did exist the way in




The numbers of treatment and control participants needed to achieve power were
insufficient in this study. The effect of this is that some significant differences may
have been lost. The small sample size was due to the high attrition rates observed.
Attrition rate was based on the number of treatment participants recruited into the
study who either did not turn up for the initial assessment or attended and did not
complete therapy. A total of 44 participants were assigned to the treatment group this
would have been sufficient to detect a small to moderate effect size, however, only
12 completed therapy. There are a number of possible reasons for the high attrition
rate.
Firstly, individuals with chronic tension type headache are often involved in
psychosocial difficulties and are experiencing substantial distress. As with somatic
patients, however, they tend to use bodily symptoms to communicate, possibly
because they have difficulties in expressing their feelings in words. Such patients
prefer general medical services to mental health services (Simon, 1992) and use
hospital services excessively (Fink, 1992). This difficulty in verbally expressing
emotions makes talking therapies a threatening concept and will engender anxiety
responses and consequent avoidance.
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Secondly, many of these patients are most likely in the early stages of change in the
transtheroretical model and would be classed as precontemplators or contemplators.
If this is the case then clinical psychology has a particular role to play in terms of
helping these individuals reach a stage at which they are thinking about change or
beginning to take action. In addition, preliminary work may not need to focus on the
headaches directly but on developing beliefs of self-efficacy in preparation for
change.
Thirdly, it is possible that a high number of individuals may be deriving some
secondary gain from maintaining illness behaviors. Reasons for this may be varied
and could include ongoing compensation claims, benefit claims, avoidance of
stressful situations such as work.
Finally, the expectations of individuals who are suffering from chronic pain and
receiving a referral to psychology may be the most significant reason for attrition. An
obvious question in this study relates to why the attrition rate was so much higher
compared to other studies that involve psychological intervention. One possible
answer is the nature of the problem being addressed. Chronic pain individuals
present with an overtly physical complaint; unlike the majority of primary care cases.
As such, chronic pain patients may view their problem as purely physical and
interpret referral to psychology as symbolic of an invalidation of the physical nature
of their complaint. As a defence to this and as a validation of their condition they
seek to preemptively reject a psychological approach. In essence, this rejection is
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based on a misunderstanding of the reason for referral as well as the need of the
patient to validate their present circumstances.
An overarching concern due to the high attrition rate is that the individuals that
remained in the study were not representative of chronic tension type headache
sufferers and that they responded to treatment for very specific reasons that would
not be found in the population as a whole.
4.3.2 Single Therapist Design
This study employed a single therapist design, which is a potential methodological
flaw. As this was a therapeutic intervention, this type of methodology makes it
difficult to establish the effect of the treatment itself over the effect of the therapist.
There is no method for separating out these effects in this study and it is therefore a
requirement of further research to employ a multi-therapist design. In practical terms,
however, this treatment is usually carried out by a single therapist attached to the
headache clinic.
4.3.3 Follow Up Data
Due to time constraints this study did not include any follow up data. Consequently,
the present study cannot determine the effectiveness of the therapy over a longer time
period. There is no obvious reason why the treatment effects would not be
maintained but this cannot be concluded without such data. In addition, there were
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some measures that did not show a significant change during the treatment period but
showed evidence of the beginnings of change. Follow up data would be useful in
terms of tracking these changes.
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4.4 Future Research
4.4.1 Predicting Treatment Success
Although the present study was useful in identifying changes in general measures
that are associated with treatment success, it was not possible to look at the general
measures in terms of their ability to predict treatment success. In doing so, treatment
might be targeted more effectively and individuals identified that are likely to
benefit.
4.4.2 Developing Preventative Therapies in Chronic Pain
While this study adds to existing literature on the effectiveness of cognitive-
behavioural programs (Compas et al. 1998; Morley et al. 1999), it was noted that the
timing of therapy was a strong determinant of treatment success. Recent studies are
now looking the specific effects of psychological preventive interventions.
Some early, secondary preventive efforts have shown promise. For example,
Waddell, Newton. (1997) reviewed 10 trials of early interventions for acute back
pain mainly in primary care settings and found that programs that encouraged
maintaining daily activities produced better results than various control conditions.
One reason for this success may be that these programs dealt with the fear and
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anxiety often associated with acute pain and believed to generate 'fear-avoidance'
behaviours that may produce disability ( Vlaeyen and Linton, 2000).
More recently, Von Korff et al. (1998) have found that a lay-led, cognitive-
behavioural program for patients with acute back pain significantly reduced worry
and disability at follow-up relative to a treatment as usual control. Therefore, there is
reason to believe that early, preventive interventions might be viable.
However, there has been some debate concerning the time point for preventive
interventions and this reflects the relative lack of investigation in 'non-patient'
populations. For example, Frank et al. (1996a) argue that, statistically speaking,
interventions for back pain prior to about 8 weeks sick leave have little value since
the natural recovery rate is high. Indeed, Sinclair et al. (1997) found that an early
intervention program based on exercise, mobilization and education administered
throughout Ontario produced little benefit in relation to 'usual' care.
However, from a psychological point of view, the development of fear, anxiety and
other processes that may generate disability (Turk; Vlaeyen and Waddell), is
probably activated quite early on. Consequently, very early, psychologically-oriented
prevention might be valuable. Nevertheless, there are relatively few attempts at
prevention in non-patient populations, and most attempts have not been
psychologically orientated. At present no studies have considered preventative
therapy for headache.
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4.4.3 Comparison with Other Therapies
The treatment results reported in this study need to be compared with other treatment
delivery formats such as group treatment, interpersonal therapy, limited contact
treatment in medical setting, telephone based treatments and internet based
treatments.
In addition, the results of this study need to be both replicated, with the removal of
the methodological flaws, and compared with studies using other treatment
modalities such as bio-feedback, massage, hypnosis and relaxation alone.
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4.5. Conclusion
The aim of this research was to examine the effectiveness of Cognitive Behavioural
Therapy on patients with Chronic Tension Type Headache referred from an acute
medical setting. This study also aimed to examine the impact of therapy on other
areas known to be implicated in the maintenance of chronic pain conditions. Results
have shown that Cognitive Behavioural Therapy is useful in reducing a number of
aspects of chronic tension type headache. Additional changes in more general
psychological measures over time suggest that Cognitive Behavioural Therapy also
successfully addresses issues that may mediate the experience of chronic pain.
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ipain stages of change
1Iquestionnaire
a'f This questionnaire is to help us to better understand the way you view
| your pain problem. Each statement describes how you may feel about this
particular problem. Please indicate the extent to which you tend to agree
or disagree with each statement. In each example, please make your
<| choice based on how you feel right now, not how you have felt in the past or
I?" how you would like to feel.
i
Circle the response that best describes how much you agree or disagree with each
T statement
1 = Strongly disagree; 2 = Disagree; 3 = Undecided or unsure; 4 = Agree;
:>■ 5 = Strongly agree
1. I have been thinking that the way I cope with 1 2 3 4 5
my pain could improve
2. I am developing new ways to cope with my 1 2 3 4 5
pain
3. I have learned some good ways to keep my 1 2 3 4 5
pain problem from interfering with my life
4. When my pain flares up, I find myself 1 2 3 4 5
automatically using coping strategies that have
worked in the past, such as relaxation exercise
or mental distraction technique
5. I am using some strategies that help me better 1 2 3 4 5
deal with my pain problem on a day-to-day
basis
6. I have started to come up with strategies to 1 2 3 4 5
help myself control my pain
7. I have recently realised that there is no 1 2 3 4 5
medical cure for my pain condition, so I want
































































































































































































































































































































































































































































































































Below is a list ofconunori symptoms of anxiety. Please carefully read each item tn the list. Show how
much you have been bothered by each symptom during the PAST WGEIC, INCLUDING TODAY, by





















Fear ofthe worst happening.
Dizzy or lightheaded.









; Indigestion or discomfort in abdomen.
Paint.
' Pace flushed.







Please list below up to seven people who may be important in the individual's life. Typical
relationships include partner, mother, father, child, sibling, close friends, plus keyworker. For
each person please circle a number from 1 to 7 to show how well he or she provides the type
of help that is listed.
The second part of each question asks you to rate how individuals would like things to be if
they were exactly as they hoped for. As before, please put a circle around one number
between 1 and 7 to show what the rating is.
Person 1 - Never Sometimes Always
1 a) Can you trust, talk to frankly and share your feelings with this
person? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
2 a) Can you lean on and turn to this person in times of difficulty?. 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
3 a) Does he/she give you practical help? , 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
4 a) Can you spend time with him/her socially? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
Person 2 -
1 a) Can you trust, talk to frankly and share your feelings with this
person? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
2 a) Can you lean on and turn to this person in times of difficulty?. 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
3 a) Does he/she give you practical help? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
4 a) Can you spend time with him/her socially? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
Person 3 -
1 a) Can you trust, talk to frankly and share your feelings with this
person? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
2 a) Can you lean on and turn to this person in times of difficulty? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
3 a) Does he/she give you practical help? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
4 a) Can you spend time with him/her socially? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7






■ Never Sometimes Always
1 a) Can you trust, talk to frankly and share your feelings with this
person? . 1 2 3 4 5 6 7
b) What rating would your ideal be? . 1 2 3 4 5 6 7
2 a) Can you lean on and turn to this person in times of
difficulty? . 1 2 3 4 5 6 7
b) What rating would your ideal be? . 1 2 3 4 5 6 7
3 a) Does he/she give you practical help? . 1 2 3 4 5 6 7
b) What rating would your ideal be? . 1 2 3 4 5 6 7
4 a) Can you spend time with him/her socially?... . 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
Person 5 -
1 a) Can you trust, talk to frankly and share your feelings with this
person? • 1 2 3 4 5 6 7
b) What rating would your ideal be? • 1 2 3 4 5 6 7
2 a) Can you lean on and turn to this person in times of
difficulty? • 1 2 3 4 5 6 7
b) What rating would your ideal be? ■ 1 2 3 4 5 6 7
3 a) Does he/she give you practical help? • 1 2 3 4 5 6 7
b) What rating^would your ideal be? • 1 2 3 4 5 6 7
4 a) Can you spend time with him/her socially?.... 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
Person 6 -
1 a) Can you trust, talk to frankly and share your feelings with this
person? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
2 a) Can you lean on and turn to this person in times of
difficulty? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
3 a) Does he/she give you practical help? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
4 a) Can you spend time with him/her socially?.... 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
Person 7 -
1 a) Can you trust, talk to frankly and share your feelings with this
person? 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 5 6 7
2 a) Can you lean on and turn to this person in times of
difficulty?: 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 b 6 7
3 a) Does he/she give you practical help? . 1 2 3 4 5 6 7
b) What rating would your ideal be? 1 2 3 4 b 8 7
4 a) Can you spend time with him/her socially?.... .12 3 4 5 6 7
b) What rating would your ideal be? . 1 2 3 4 5 6 7
PLEASE CIRCLE ONE NUMBER ONLY FOR EACH QUESTION
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jl. Agitation
0 I am no more restless or wound up than usual.
1 I feel more restless or wound up than usual.
2 I am so restless or agitated that it's hard to stay
still.
3 I am so restless oragitated that I have to keep
moving or doing something.
12. Loss of Interest
0 I have not lost interest in other people or
activities.
1 I am less interested in other people or things
than before.
2 I have lost most ofmy interest in other people
or things.
3 It's hard to get interested in anything.
13. Indecisiveness
0 I make decisions about as well as ever.
1 I find it more difficult to make decisions than
usual.
2 I have much greater difficulty in making
decisions tham-tased to.
3 I have trouble making any decisions.
14. Worthlessness
0 I do not feel I am worthless.
1 I don't consider myself as worthwhile and useful
as I used to.
2 I feel more worthless as compared to other
people.
3 I feel utterly worthless.
15. Loss of Energy
0 I have as much energy as ever.
1 I have less energy than I used to have.
2 I don't have enough energy to do very much.
3 I don't have enough energy to do anything.
16. Changes in Sleeping Pattern
0 I have not experienced any change in my
sleeping pattern.
la 11 sleep somewhat more than usual.
lb I sleep somewhat less than usual.
17. Irritability
0 I am no more irritable than usual.
1 I am more irritable than usual.
2 I am much more irritable than usual.
3 I am irritable all the time.
18. Changes in Appetite
0 I have not experienced any change in my
appetite.
la My appetite is somewhat less than usual,
lb My appetite is somewhat greater than usual.
2a My appetite is much less than before.
2b My appetite is much greater than usual.
3a I have no appetite at all.
3b I crave food all the time.
*
19. Concentration Difficulty
0 I can concentrate as well as ever.
1 I can't concentrate as well as usual.
2 ' It's hard to keep my mind on anything for
very long.
3 I find I can't concentrate on anything.
20. Tiredness or Fatigue
0 I am no more tired or fatigued than usual.
1 I get more tired or fatigued more easily than
usual.
2 I am too tired or fatigued to do a lot of the things
I used to do.
3 I am too tired or fatigued to do most of the
things I used to do.
21. Loss of Interest in Sex
0 I have not noticed any recent change in my
interest in sex.
1 I am less interested in sex than I used to be.
2 I am much less interested in sex now.
3 I have lost interest in sex completely.
2a I sleep a lot more than usual.
2b I sleep a lot less than usual.
3a I sleep most of the day.
3b I wake up 1-2 hours early and can't get back
to sleep.
OTICE: This form is printed with both blue and black ink. If your
)py does not appear this way, it has been photocopied in









instructions: This questionnaire consists of 21 groups of statements. Please read each group of statements carefully, and
ten pick out the one statement in each group that best describes the way you have been feeling during the past two
Keeks, including today. Circle the number beside the statement you have picked. If several statements in the group
eem to apply equally well, circle the highest number for that group. Be sure that you do not choose more than one
latement for any group, including Item 16 (Changes in Sleeping Pattern) or Item 18 (Changes in Appetite).
1. Sadness
0 I do not feel sad.
1 I feel sad much of the time.
2 I am sad all the time.
3 I am so sad or unhappy that I can't stand it.
2. Pessimism
0 I am not discouraged about my future.
1 I feel more discouraged about my future than I
used to be.
2 I do not expect things to work out for me.
3 I feel my future is hopeless and will only get
worse.
3. Past Failure
0 I do not feel like a failure.
1 I have failed more than I should have.
2 As I look back, I see a lot of failures.
3 I feel I am a total failure as a person.
4. Loss of Pleasure
0 I get as much pleasure as I ever did from the
things I enjoy.
1 I don't enjoy things as much as I used to.
2 I get very little pleasure from the things I used
to enjoy.
3 I can't get any pleasure from the things I used
to enjoy.
5. Guilty Feelings
0 I don't feel particularly guilty.
1 I feel guilty over many things I have done or
should have done.
2 I feel quite guilty most of the time.
3 I feel guilty all of the time.
6. Punishment Feelings
0 I don't feel I am being punished.
1 I feel I may be punished.
2 I expect to be punished.
3 I feel I am being punished.
7. Self-Dislike
0 I feel the same about myself as ever.
1 I have lost confidence in myself.
2 I am disappointed in myself.
3 I dislike myself.
8. Self-Criticalness
0 I don't criticize or blame myself more than usual.
1 I am more critical ofmyself than I used to be.
2 I criticize myself for all ofmy faults.
3 I blame myself for everything bad that happens.
9. Suicidal Thoughts or Wishes
0 I don't have any thoughts of killing myself.
1 I have thoughts of killing myself, but I would
not carry them out.
2 I would like to kill myself.
3 I would kill myself if I had the chance.
10. Crying
0 I don't cry anymore than I used to.
1 I cry more than I used to.
2 I cry over every little thing.
3 I feel like crying, but I can't.
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0 I am no more restless or wound up than usual.
1 I feel more restless or wound up than usual.
2 I am so restless or agitated that it's hard to stay
still.
3 I am so restless or agitated that I have to keep
moving or doing something.
I Loss of Interest
0 I have not lost interest in other people or
activities.
1 I am less interested in other people or things
than before.
2 I have lost most of my interest in other people
or things.
3 It's hard to get interested in anything.
13. Indecisiveness
0 I make decisions about as well as ever.
1 I find it more difficult to make decisions than
usual.
2 I have much greater difficulty in making
decisions than I used to.
3 I have trouble making any decisions.
14. Worthlessness
0 I do not feel I am worthless.
1 I don't consider myself as worthwhile and useful
as I used to.
2 I feel more worthless as compared to other
people.
3 I feel utterly worthless.
15. Loss of Energy
0 I have as much energy as ever.
1 I have less energy than I used to have.
2 I don't have enough energy to do very much.
3 I don't have enough energy to do anything.
16. Changes in Sleeping Pattern




I sleep somewhat more than usual.
I sleep somewhat less than usual.
2a I sleep a lot more than usual.
2b I sleep a lot less than usual.
3a I sleep most of the day.
3b I wake up 1-2 hours early and can't get back
to sleep.
17. Irritability
0 I am no more irritable than usual.
1 I am more irritable than usual.
2 I am much more irritable than usual.
3 I am irritable all the time.
18. Changes in Appetite
0 I have not experienced any change in my
appetite.
la My appetite is somewhat less than usual,
lb My appetite is somewhat greater than usual.
2a My appetite is much less than before.
2b My appetite is much greater than usual.
3a I have no appetite at all.
3b I crave food all the time.
19. Concentration Difficulty
0 I can concentrate as well as ever.
1 I can't concentrate as well as usual.
2 It's hard to keep my mind on anything for
very long.
3 I find I can't concentrate on anything.
20. Tiredness or Fatigue
0 I am no more tired or fatigued than usual.
1 I get more tired or fatigued more easily than
usual.
2 I am too tired or fatigued to do a lot of the things
I used to do.
3 I am too tired or fatigued to do most of the
things I used to do.
21. Loss of Interest in Sex
0 I have not noticed any recent change in my
interest in sex.
1 I am less interested in sex than I used to be.
2 I am much less interested in sex now.
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LOCUS OF CONTROL SCALE (FORM A)
1HM11
This is a questionnaire designed to determine the way in which different people view certain important
health-related issues. Each item is a belief statement with which you may agree or disagree. Beside each
statement is a scale which ranges from strongly disagree (1) to strongly agree (6). For each item we would
like you to circle the number that represents the extent to which you disagree or agree with the statement.
The more strongly you agree with a statement, then the higher will be the number you circle. The more
strongly you disagree with a statement, then the lower will be the number you circle. Please make sure that
you answer every item and that you circle only one number per item. This is a measure of your personal
beliefs: obviously, there are no right or wrong answers. *
Please answer these items carefully, but do not spend too much time on any one item. As much as you
can, try to respond to each item independently. When making your choice, do not be influenced by your
previous choices. It is important that you respond according to your actual beliefs and not according to how
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1. If 1 get sick, it is my oyyn behaviour which determines how
soon 1 get well again. 1 2 3 4 5 6
2. No matter what 1 do, if 1 am going to get sick, 1 will get sick. 1 2 3 4 5 6
3. Having regular contact with my doctor is the best way for me
to avoid illness. 1 2 3 4 5 6
4. Most things that affect my health happen to me by accident. 1 2 3 4 5 6
5. Whenever 1 don't feel well, 1 should consult a medically
trained professional. 1 2 3 4 5 6
6. 1 am in control of my health. 1 2 3 4 5 6
7. My family has a iot to do with my becoming sick or staying
healthy. 1 2 3 4 5 6
8. When 1 get sick, 1 am to blame. 1 2 3 4 5 6
9. Luck plays a big part in determining how soon 1 will recover
from an illness. 1 2 3 4 5 6
10. Health professionals control my health. 1 2 3 4 5 6
11. My good health is largely a matter of good fortune. 1 2 3 4 5 6
12. The main thing which affects my health is what 1 myself do. 1 2 3 4 5 6
13. If 1 take care of myself, 1 can avoid illness. 1 2 3 4 5 6
14. When 1 recover from an illness, it's usually because other
people (for example, doctors, nurses, family, friends) have
been taking good care of me. 1 2 3 4 5 6
15. No matter what 1 do, I'm likely to get sick. 1 2 3 4 5 6
16. if it's meant to be, 1 will stay healthy. 1 2 3 4 5 6
17. If 1 take the right actions, 1 can stay healthy. 1 2 3 4 5 6
18. Regarding my health, 1 can only do what my doctor tells me
to do. 1 2 3 4 5 6
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LOCUS OF CONTROL SCALE (FORM B)
Name:
Date: -.7. Record Number:
This is a questionnaire designed to determine the way in which different people view certain important
health-related issues. Each item is a belief statement with which you may agree or disagree. Beside each
statement is a scale which ranges from strongly disagree (1) to strongly agree (6). For each item we would
like you to circle the number that represents the extent to which you disagree or agree with the statement.
The more strongly you agree with a statement, then the higher will be the number you circle. The more
strongly you disagree with a statement, then the lower will be the number you circle. Please make sure that
you answer every item and that you circle only one number per item. This is a measure of your personal
beliefs: obviously, there are no right or wrong answers.
Please answer these items carefully, but do not spend too much time on any one item. As much as you
can, try to respond to each item independently.When making your choice, do not be influenced by you&
previous choices. It is important that you respond according to your actual beliefs and not according to how









1. If I beconpsrstck, I have the power to make myself well again. 1 2 3 4 5 6
2. Often I feel that no matter what I do, if I am going to get sick,
I will get sick. 1 2 3 4 5 6
3. If I see an excellent doctor regularly, I am less likely to have
health problems. 1 2 3 4 5 6
4. It seems that my health is greatly influenced by accidental
happenings. 1 2 3 4 5 6
5. I can only maintain my health by consulting health
professionals. 1 2 3 4 5 6
6. I am directly responsible for my health. 1 2 3 4 5 6
7. Other people play a big part in whether I stay healthy or
become sick. 1 2 3 4 5 6
8. Whatever goes wrong with my health is my own fault. 1 2 3 4 5 6
9. When I am sick, I just have to let nature run its course. 1 2 3 4 5 6
10. Health professionals keep me healthy. 1 2 3 4 5 6
11. When I stay healthy, I'm just plain lucky. 1 2 3 4 5 6
12. My physical well-being depends on how well I take care of
myself. 1 2 3 4 5 6
13. When 1 feel ill, know it is because 1 have not been taking
care of myself properly. 1 2 3 4 5 6
14. The type of care 1 receive from other people is what is
responsible for how well 1 recover from an illness. 1 2 3 4 5 6
15. Even when 1 take care of myself, it's easy to get sick. 1 2 3 4 5 6
16. When 1 become ill, it's a matter of fate. 1 2 3 4 5 6
17. 1 can pretty much stay healthy by taking good care of myself. 1 2 3 4 5 6
18. Following doctor's orders to the letter is the best way for me
to stay healthy. 1 2 3 4 5 6
©Wallston, 1978. From 'Development of the multidimensional health locus of control (MHLC) scales', Health Education
Monographs, 6, 161-70. Reproduced with the kind permission of the author.
This measure is part of Measures in Health Psychology:A User's Portfolio, written and compiled by Professor John
Weinman, Dr Stephen Wright and Professor Marie Johnston. Once the invoice has been paid, it may be photocopied
for use within the purchasing institution only. Published by The NFER-NELSON Publishing Company Ltd, Darville
House, 2 Oxford Road East, Windsor, Berkshire SL4 1DF, UK. Code 4920 10 4
©
